Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000273387	ENSG00000273387	3.03199801344069	3.65111091061994e-6	M2_vs_M1	HSALNG0134940	anti_sense	Q75	hsa-miR-762,hsa-miR-4447,hsa-miR-4505,hsa-miR-6735-5p	Fev/fec ratio,-	SELENOM	HS3ST1
ENSG00000290418	TPTEP1	1.29566082148959	1.56374771266529e-14	M2_vs_M1	HSALNG0133819	integenic	Not conserved	NA	-	IL17RA	DBNDD1
ENSG00000245552	LNCRNA-IUR	-3.0130903002415	8.42797122753479e-7	M2_vs_M1	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1	AGK
ENSG00000254027	LNMICC	1.64906002013248	4.53958320859462e-6	M2_vs_M1	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	MARK4
ENSG00000248932	COPB2-DT	1.29928053613123	4.85426337997301e-5	M2_vs_M1	HSALNG0029337	integenic	Not conserved	hsa-miR-765	NA	MRPS22	CDKL5
ENSG00000203497	PDCD4-AS1	1.06825881861658	0.0140656709597184	M2_vs_M1	HSALNG0080613	anti_sense	Q50	hsa-miR-6089	Aspartate aminotransferase measurement,-	BBIP1	DLEC1
ENSG00000267197	ENSG00000267197	-3.74582452067594	0.00228008671525276	M2_vs_M1	HSALNG0123939	sense	Not conserved	NA	NA	KEAP1	DLEC1
ENSG00000257027	ENSG00000257027	-1.47010053450997	4.616647553549359e-11	M2_vs_M1	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	ZNF200
ENSG00000248323	LUCAT1	-1.2759599221413	1.11769081756403e-14	M2_vs_M1	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3	CALCOCO1
ENSG00000267397	ENSG00000267397	2.118496364158	0.0471394328055504	M2_vs_M1	HSALNG0120911	integenic	Not conserved	NA	NA	GALNT1	MDH1
ENSG00000287123	ENSG00000287123	3.59631137417458	2.7617351543353e-4	M2_vs_M1	HSALNG0146118	integenic	Q50	hsa-miR-619-5p,hsa-miR-4437,hsa-miR-6124,hsa-miR-6813-5p	-	SLC1A4	ZMYND11
ENSG00000273145	ENSG00000273145	1.00824477022185	0.0176106782352128	M2_vs_M1	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA	RNF10
ENSG00000290927	ENSG00000290927	-2.09434761845974	2.35801378681448e-34	M2_vs_M1	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	EIPR1
ENSG00000232053	ENSG00000232053	-1.00865729859151	0.00834989635423374	M2_vs_M1	HSALNG0061598	integenic	Q75	hsa-miR-663b	NA	STMP1	FUT8
ENSG00000205414	ENSG00000205414	3.53940392382768	2.59244085717199e-25	M2_vs_M1	HSALNG0144931	anti_sense	Q50	NA	NA	SNX20	RFC1
ENSG00000223704	LINC01422	1.41589189111595	0.0121044380871557	M2_vs_M1	HSALNG0134677	integenic	Not conserved	hsa-miR-7108-3p	-	CRYBA4	MYOM2
ENSG00000255197	ENSG00000255197	1.99878650481164	2.1694444184705503e-58	M2_vs_M1	HSALNG0143174	anti_sense	Q90	NA	Alcohol consumption measurement	SPI1	PHKA2
ENSG00000234394	LINC03025	-7.08125044797397	6.55866647380753e-7	M2_vs_M1	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5	DKK3
ENSG00000286176	ENSG00000286176	3.12789341989532	0.00286207906907079	M2_vs_M1	HSALNG0032624	anti_sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Drugs used in diabetes use measurement,Glucose measurement,Hba1c measurement,-,Cholesteryl ester 16:0 measurement,Longevity	PPP2R2C	PIK3CB
ENSG00000291104	BTN2A3P	-1.21048271584741	4.52295522347164e-5	M2_vs_M1	HSALNG0048771	integenic	Not conserved	NA	NA	BTN3A1	KCNQ1
ENSG00000253320	MAILR	-2.91373669860115	8.333251660171199e-32	M2_vs_M1	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	EIF2AK2
ENSG00000234432	LINC02983	3.35108098195784	2.9083139464451e-5	M2_vs_M1	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	SOAT1
ENSG00000226137	BAIAP2-DT	1.84098113852797	2.44209624045201e-69	M2_vs_M1	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	USP13
ENSG00000291091	SDHAP4	1.24406778146563	1.04888764046642e-34	M2_vs_M1	HSALNG0032044	integenic	Not conserved	hsa-miR-4281	NA	BDH1	TBXAS1
ENSG00000234506	LINC01506	1.32970119327304	0.0228360566478709	M2_vs_M1	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	SFSWAP
ENSG00000246640	PICART1	2.74214047790525	6.49764125323033e-6	M2_vs_M1	HSALNG0117242	anti_sense	Q90	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-10392-3p	-	SAMD14	ABCA7
ENSG00000253838	ENSG00000253838	-7.97541453537103	1.68487699605858e-78	M2_vs_M1	HSALNG0150187	sense	Q50	NA	-	IDO1	NTN1
ENSG00000235314	LINC00957	1.11157758441575	1.8601729464316e-4	M2_vs_M1	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL	LRRC40
ENSG00000287978	ENSG00000287978	2.15302202317141	0.0165904663786827	M2_vs_M1	HSALNG0141895	integenic	Not conserved	NA	NA	POLR3GL	MYO9A
ENSG00000232656	IDI2-AS1	-1.08693392822998	0.00558200307991882	M2_vs_M1	HSALNG0075528	anti_sense	Q75	hsa-miR-3940-5p,hsa-miR-4433a-3p	Response to candesartan,-	GTPBP4	DNTTIP2
ENSG00000274422	ENSG00000274422	2.43430631612269	2.77336609640694e-5	M2_vs_M1	HSALNG0134310	integenic	Not conserved	hsa-miR-6132,hsa-miR-8072	-	ZNF280B	PDK3
ENSG00000287778	ENSG00000287778	2.05181921363717	6.2005096703383e-7	M2_vs_M1	HSALNG0032926	integenic	Not conserved	NA	NA	DRD5	ACSL4
ENSG00000273828	ENSG00000273828	-1.64216506288083	0.00174666570232713	M2_vs_M1	HSALNG0130476	anti_sense	Q50	NA	-	CD40	SIRT2
ENSG00000180066	LINC02870	1.28143925630725	0.0146336393636448	M2_vs_M1	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	DGCR2
ENSG00000287736	PTCSC1	1.20920537627355	0.0128386086884796	M2_vs_M1	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	ATP6AP1
ENSG00000235910	APOA1-AS	-2.55003132258548	0.0138728478551199	M2_vs_M1	HSALNG0087417	anti_sense	Not conserved	NA	Blood protein measurement,High density lipoprotein cholesterol measurement,Sleep duration; Triglyceride measurement,Serum metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; High density lipoprotein cholesterol measurement,-	APOC3	ACAP1
ENSG00000272068	BCAN-AS1	1.94519307220731	1.3891110922444e-4	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	MAP3K13
ENSG00000267751	BSG-AS1	1.98261281211081	1.03313144193663e-6	M2_vs_M1	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	MAP3K13
ENSG00000288927	ENSG00000288927	2.18297814884732	0.00513144730988058	M2_vs_M1	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	SLC24A1
ENSG00000230943	LINC02541	-2.38200344024424	1.95597029878933e-10	M2_vs_M1	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	VPS9D1
ENSG00000229331	GK-IT1	-3.19629378509069	1.4892069380855e-4	M2_vs_M1	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p	NA	GK	MARK3
ENSG00000284633	ENSG00000284633	-3.48201439606097	8.01571878259751e-13	M2_vs_M1	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	DLG1
ENSG00000286004	ENSG00000286004	-1.56127288820699	0.00109159038214308	M2_vs_M1	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	SEC31B
ENSG00000290873	LINC03009	-1.74669825024885	1.79950473989811e-5	M2_vs_M1	NA	NA	NA	NA	NA	UPK3B	KIFAP3
ENSG00000289173	ENSG00000289173	-5.70759298704791	0.00242814783074988	M2_vs_M1	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	CAPN6
ENSG00000222032	ENSG00000222032	5.74853337067492	0.00433038200496628	M2_vs_M1	HSALNG0023343	integenic	Q75	hsa-miR-6865-5p	Body height,-	COL6A3	FAM76B
ENSG00000230479	ENSG00000230479	2.09430921948871	0.00918774481338716	M2_vs_M1	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	SLC25A43
ENSG00000273143	DUSP5-DT	1.01780767154344	0.0341632130111427	M2_vs_M1	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	N4BP2
ENSG00000289880	ENSG00000289880	-3.96901331737179	2.46886696713829e-10	M2_vs_M1	NA	NA	NA	NA	NA	FAM177B	THOC1
ENSG00000260101	AFTPH-DT	1.44373924699634	3.2505354001066503e-10	M2_vs_M1	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	SLC35C2
ENSG00000251432	LINC02615	1.34425485713878	0.0320995278478592	M2_vs_M1	HSALNG0037069	integenic	Q50	NA	NA	LARP1B	EXD2
ENSG00000270164	LINC01480	3.65740983767288	1.99391012848245e-60	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	TRAF5
ENSG00000254872	LINC02688	4.98395171915742	3.19507708083556e-7	M2_vs_M1	HSALNG0082072	integenic	Q50	hsa-miR-874-3p,hsa-miR-4463	NA	MUC2	TRAF5
ENSG00000205444	KU-MEL-3	-6.55246493775522	7.34830450757571e-6	M2_vs_M1	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL	P2RX5
ENSG00000291005	NBPF25P	1.91701244592666	7.25158369661267e-5	M2_vs_M1	HSALNG0006737	anti_sense	Not conserved	NA	Breast carcinoma,-	PDZK1	DIS3
ENSG00000227039	ITGB2-AS1	-2.1414950925926	8.60596344912324e-31	M2_vs_M1	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9	SF3B2
ENSG00000253891	ENSG00000253891	-6.86190967741689	1.24776501487451e-6	M2_vs_M1	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	RFX2
ENSG00000204044	SLC12A5-AS1	-1.0992877647649	1.82893284720659e-6	M2_vs_M1	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	SMOX
ENSG00000261644	CYLD-AS1	-2.07890430013286	1.19972464753525e-17	M2_vs_M1	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	PLEKHG2
ENSG00000234869	LINC02925	2.17057080693034	1.41791110777346e-5	M2_vs_M1	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	JPH4
ENSG00000259065	MIDEAS-AS1	2.12050711515183	0.0037347854791798	M2_vs_M1	HSALNG0102380	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4323,hsa-miR-3135b,hsa-miR-4472	-	PTGR2	CBX5
ENSG00000286162	ENSG00000286162	-2.44889234737686	1.55371957197499e-24	M2_vs_M1	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	JAK2
ENSG00000205885	C1RL-AS1	-4.16550671370361	8.612989777175861e-52	M2_vs_M1	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	UPB1
ENSG00000231663	COA6-AS1	1.83029885158555	0.0324453327744435	M2_vs_M1	HSALNG0011591	anti_sense	Q50	hsa-miR-6763-5p	-	TARBP1	SRRD
ENSG00000225964	NRIR	-5.56694470169695	4.2922783651076e-60	M2_vs_M1	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	GTPBP1
ENSG00000277089	CCL3-AS1	3.99431086944799	1.46168120788783e-39	M2_vs_M1	HSALNG0116003	anti_sense,sense	Q75	hsa-miR-604,hsa-miR-4726-5p,hsa-miR-6077,hsa-miR-6089,hsa-miR-6743-5p	Blood protein measurement,C-c motif chemokine 3 measurement	CCL18	AP1B1
ENSG00000250041	ENSG00000250041	2.62482006925417	9.70858407560345e-29	M2_vs_M1	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	MCAT
ENSG00000197989	SNHG12	1.10825491219862	3.35757268072404e-32	M2_vs_M1	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	KIAA0930
ENSG00000258602	LINC01629	-2.56558215434576	1.63674646635001e-10	M2_vs_M1	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A	CSF2RB
ENSG00000233621	ZC3H12A-DT	-1.50643953425742	7.34049933994925e-32	M2_vs_M1	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	PRMT5
ENSG00000268895	A1BG-AS1	-1.12901502966059	5.26072543080656e-8	M2_vs_M1	HSALNG0127948	anti_sense	Not conserved	hsa-miR-1204,hsa-miR-4505,hsa-miR-4535,hsa-miR-4695-5p,hsa-miR-4707-5p,hsa-miR-6081	-	ZSCAN22	PSMA3
ENSG00000263120	ENSG00000263120	-2.13482898317885	0.0261975481804914	M2_vs_M1	HSALNG0117612	sense	Not conserved	NA	-	SCPEP1	RIN3
ENSG00000231131	LNCAROD	-3.0483113447218	1.27359787628982e-8	M2_vs_M1	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	SUSD6
ENSG00000289100	ENSG00000289100	-2.90995048904438	7.979903701191251e-9	M2_vs_M1	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p	NA	PFDN6	ARHGAP5
ENSG00000282164	PEG13	2.7208630343719	0.026692617164162	M2_vs_M1	HSALNG0150502	sense	Not conserved	NA	NA	TRAPPC9	PFDN4
ENSG00000237976	RFX5-AS1	-1.86314895713975	0.0394917776875303	M2_vs_M1	HSALNG0007143	anti_sense	Q90	NA	-	PSMB4	RNMT
ENSG00000273341	ENSG00000273341	1.62487172587172	4.0400957497669294e-11	M2_vs_M1	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	ANKRD12
ENSG00000229272	LINC03036	4.18138246746367	9.206167901146087e-12	M2_vs_M1	HSALNG0081008	integenic	Not conserved	NA	NA	EIF3A	PORCN
ENSG00000277287	ENSG00000277287	1.2414893051755	0.00248583273894059	M2_vs_M1	HSALNG0128242	integenic	Not conserved	NA	-	ITPA	GLA
ENSG00000290718	FAM95B1	3.15867532942436	5.2280094922453e-4	M2_vs_M1	HSALNG0071261	integenic	Not conserved	NA	-	SPATA31A1	ZNF821
ENSG00000287771	ENSG00000287771	5.29229765074416	0.00526174131468782	M2_vs_M1	HSALNG0017397	integenic	Q50	NA	Ulcerative colitis; Crohn's disease,Autism spectrum disorder; Ulcerative colitis; Ankylosing spondylitis; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder,-	IL1R1	COTL1
ENSG00000269072	ENSG00000269072	2.23168542929923	0.020182908552885	M2_vs_M1	HSALNG0127186	anti_sense	Not conserved	hsa-miR-4463	Sialic acid-binding ig-like lectin 9 measurement,Blood protein measurement; Alkaline phosphatase measurement,Cortical thickness,Blood protein measurement,Granulocyte percentage of myeloid white cells; Blood protein measurement; Cerebrospinal fluid biomarker measurement; Monocyte percentage of leukocytes,Blood protein measurement; Reticulocyte measurement; Cerebrospinal fluid biomarker measurement,C-reactive protein measurement; Body mass index; Protein measurement; Sialic acid-binding ig-like lectin 9 measurement; Blood protein measurement,-	CTU1	ZNF500
ENSG00000230487	PSMG3-AS1	1.21217872849766	2.31026208607989e-15	M2_vs_M1	HSALNG0055664	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-762,hsa-miR-1268b,hsa-miR-5589-5p,hsa-miR-6089	-	MAFK	HOMER2
ENSG00000232545	ENSG00000232545	-1.4918794004817	0.0059082640392746	M2_vs_M1	HSALNG0134472	sense	Q90	hsa-miR-4529-5p,hsa-miR-6132	NA	CABIN1	KCNN4
ENSG00000235531	MSC-AS1	-1.9491894281198	5.863131363441828e-43	M2_vs_M1	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	TYK2
ENSG00000272338	ENSG00000272338	1.78843449591123	0.0318984101762296	M2_vs_M1	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	PLA2G4C
ENSG00000253931	LINC02990	3.98063557920221	1.72168082795002e-11	M2_vs_M1	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	FKBP8
ENSG00000267296	CEBPA-DT	2.02195391833768	6.01683835881986e-20	M2_vs_M1	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	HIBADH
ENSG00000264290	ENSG00000264290	1.70615940336062	0.00806005149756448	M2_vs_M1	HSALNG0115587	sense	Q75	hsa-miR-6775-3p	-	TP53I13	CASP2
ENSG00000261618	LINC02605	-5.66212833292604	6.05757505930067e-38	M2_vs_M1	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	EZH2
ENSG00000291006	ENSG00000291006	-1.56889354252811	2.37802778614639e-10	M2_vs_M1	NA	NA	NA	NA	NA	TMEM14A	FSD1L
ENSG00000286646	MAP3K5-AS2	3.6490335968388	8.72206465438866e-85	M2_vs_M1	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	TNFSF8
ENSG00000264456	ENSG00000264456	-1.20701329998855	2.61093101396255e-5	M2_vs_M1	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	KANK1
ENSG00000215458	AATBC	2.15224290740448	2.81273188306247e-31	M2_vs_M1	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	RGP1
ENSG00000286067	ENSG00000286067	-1.47449705695772	6.36247578999905e-14	M2_vs_M1	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	RIGI
ENSG00000281756	C2-AS1	-2.37242138510097	0.00940495048422056	M2_vs_M1	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	RIGI
ENSG00000261625	ENSG00000261625	2.64125730311153	0.00128544014781112	M2_vs_M1	HSALNG0085289	integenic	Not conserved	NA	NA	MRGPRF	BAG1
ENSG00000277007	ENSG00000277007	4.07982634844079	3.2821159269373e-4	M2_vs_M1	HSALNG0010635	sense	Q75	NA	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1	SH3PXD2A
ENSG00000284669	ENSG00000284669	-1.89910400267245	0.00509294199596039	M2_vs_M1	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	CCNY
ENSG00000281005	LINC00921	1.79926774659118	4.99098901392541e-7	M2_vs_M1	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	CCNY
ENSG00000288919	ENSG00000288919	-3.34643185058754	0.0176316997407423	M2_vs_M1	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	CBX1
ENSG00000260751	ENSG00000260751	-1.97028262869858	0.0225364246145837	M2_vs_M1	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	GOSR1
ENSG00000216863	LY86-AS1	2.58689652194775	8.45239117376651e-51	M2_vs_M1	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	ALDH3A1
ENSG00000225342	LRRK2-DT	-2.76152750889255	1.24071844086393e-9	M2_vs_M1	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	COL1A1
ENSG00000256508	MRGPRF-AS1	3.33182547267908	5.55083148027901e-40	M2_vs_M1	HSALNG0085291	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4710,hsa-miR-6735-3p,hsa-miR-6792-5p,hsa-miR-6803-5p,hsa-miR-6808-5p,hsa-miR-7108-3p	Reticulocyte count,Hair colour measurement,Mosquito bite reaction size measurement,-	TPCN2	VAT1
ENSG00000288954	ENSG00000288954	-8.70536256843018	2.2286919704322e-22	M2_vs_M1	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	FNBP4
ENSG00000233077	LINC01271	-2.31995012655248	1.71491806606071e-7	M2_vs_M1	HSALNG0130754	integenic	Q50	hsa-miR-6875-3p	Thyroid stimulating hormone measurement,Monocyte count,-	PEDS1	FOXRED1
ENSG00000226091	LINC00937	-4.86060779287854	7.39659533507969e-84	M2_vs_M1	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	SLC6A12
ENSG00000251179	TMEM92-AS1	-5.87400248100576	4.2870126187758e-4	M2_vs_M1	HSALNG0117279	anti_sense	Not conserved	hsa-miR-762,hsa-miR-4505,hsa-miR-6813-5p	NA	COL1A1	CAND1
ENSG00000237372	ENSG00000237372	-4.22846990552877	1.09906732769719e-30	M2_vs_M1	HSALNG0072619	integenic	Not conserved	NA	NA	GADD45G	BTN3A3
ENSG00000233360	PDXP-DT	-1.80704062894431	0.0252743688172684	M2_vs_M1	HSALNG0135333	anti_sense	Q75	hsa-miR-6749-3p	-	LGALS2	TMEM14C
ENSG00000289365	ENSG00000289365	-3.2467406754685	1.08919314915793e-6	M2_vs_M1	HSALNG0139497	integenic	Q50	NA	NA	NXT2	GPLD1
ENSG00000205611	LINC01597	-5.04555730206233	0.0274275810039997	M2_vs_M1	HSALNG0129452	integenic	Not conserved	hsa-miR-4433a-3p	-	DEFB116	FIG4
ENSG00000289977	ENSG00000289977	3.08996509175914	1.30996519670621e-6	M2_vs_M1	HSALNG0114255	integenic	Not conserved	NA	NA	ACADVL	SLC16A10
ENSG00000260188	ENSG00000260188	4.13355504894954	4.035817887883e-4	M2_vs_M1	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	ADGRG6
ENSG00000242516	LINC00960	-2.72954313474799	3.17727280529714e-7	M2_vs_M1	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	DUSP22
ENSG00000256746	MADD-AS1	-1.9882398759045	1.70261539149889e-16	M2_vs_M1	HSALNG0084043	intronic_antisense	Q75	hsa-miR-6747-3p	NA	ACP2	HMGCS1
ENSG00000276248	ENSG00000276248	1.0673338316997	0.0421145295408299	M2_vs_M1	HSALNG0099603	sense	Not conserved	NA	NA	TMCO3	NNT
ENSG00000234572	LINC01800	3.81854003396463	8.08259332694941e-29	M2_vs_M1	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2	FAF2
ENSG00000269553	ENSG00000269553	2.80745406772181	3.2583710345285e-5	M2_vs_M1	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	RNF130
ENSG00000259805	ENSG00000259805	3.18844059128643	0.0295662143850954	M2_vs_M1	HSALNG0107722	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-619-5p	Bmi-adjusted hip circumference,Coronary artery disease,Chronic obstructive pulmonary disease,Mucocutaneous lymph node syndrome,Intelligence,Glomerular filtration rate,Basophil count; Basophil percentage of leukocytes,-	RAMAC	LNPEP
ENSG00000284428	ENSG00000284428	1.19365657095185	0.0394150465889616	M2_vs_M1	HSALNG0125033	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-632,hsa-miR-4318,hsa-miR-1268b,hsa-miR-4673,hsa-miR-4722-5p,hsa-miR-6075	Lysophosphatidylcholine 20:3 measurement,Hyperuricemia; Gout,Forced expiratory volume; Smoking status measurement,Pain measurement; Response to non-steroidal anti-inflammatory,-	NA	PCDH12
ENSG00000234389	ENSG00000234389	-6.7796453497406	1.09447971295136e-6	M2_vs_M1	HSALNG0017421	sense	Not conserved	hsa-miR-6811-3p	NA	IL18RAP	PPP2CA
ENSG00000233559	LINC00513	1.7560091372479	0.00124475151666718	M2_vs_M1	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	DPYSL3
ENSG00000255874	PRECSIT	-1.37516203873967	5.1437931224882e-4	M2_vs_M1	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	USP4
ENSG00000289053	ENSG00000289053	-3.15228346730496	2.1853793848942e-4	M2_vs_M1	HSALNG0056798	integenic	Q50	NA	Interleukin 18 measurement,Gestational age,Monocyte percentage of leukocytes,-	NFE2L3	GORASP1
ENSG00000214922	HLA-F-AS1	-1.35426335316919	1.99496973292437e-5	M2_vs_M1	HSALNG0049088	anti_sense	Not conserved	hsa-miR-575,hsa-miR-8485	Age at menopause,Cytokine measurement,Psoriatic arthritis,Bmi-adjusted waist-hip ratio; Hodgkins lymphoma, mixed cellularity,Lung carcinoma,Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement,Urate measurement,-	ZFP57	ABCC5
ENSG00000233237	LINC00472	-4.02372882791428	2.33531447159159e-16	M2_vs_M1	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	OTOF
ENSG00000258441	LINC00641	-1.47198414139642	3.247143875403479e-16	M2_vs_M1	HSALNG0099873	integenic	Not conserved	NA	Bipolar disorder,-	HNRNPC	TANC1
ENSG00000254419	ENSG00000254419	1.11629338411659	0.00806972430394186	M2_vs_M1	HSALNG0131276	sense	Not conserved	NA	NA	NPEPL1	SLC30A3
ENSG00000290858	ENSG00000290858	-6.3406347677366	7.35826638759284e-5	M2_vs_M1	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM	GALNT3
ENSG00000255050	ENSG00000255050	-2.13482525267979	0.0262958884406634	M2_vs_M1	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	WIPF1
ENSG00000263069	RNF213-AS1	-2.00799370700435	1.5425963767611e-16	M2_vs_M1	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	PLEKHA3
ENSG00000289881	ENSG00000289881	3.18853231795944	0.029549255559159	M2_vs_M1	HSALNG0004816	integenic	Not conserved	hsa-miR-4534,hsa-miR-5047,hsa-miR-6830-5p	Survival time; Lung carcinoma,-	SSX2IP	PARD3B
ENSG00000287497	ENSG00000287497	2.71926266181151	2.48910072966103e-6	M2_vs_M1	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	ALMS1
ENSG00000291158	LINC00869	-2.18185424605477	5.79018750469201e-7	M2_vs_M1	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	S100PBP
ENSG00000291174	ENSG00000291174	-1.76090811040732	7.7232172184231e-4	M2_vs_M1	NA	NA	NA	NA	NA	FRMD8	TRIM62
ENSG00000290054	ENSG00000290054	5.61529668638258	3.8543943519189e-4	M2_vs_M1	HSALNG0031957	sense	Not conserved	NA	NA	PIGX	IVNS1ABP
ENSG00000274020	LINC01138	-1.82293396235757	1.65609026039117e-8	M2_vs_M1	HSALNG0006866	integenic	Not conserved	NA	NA	PPIAL4G	ADPRS
ENSG00000281103	TRG-AS1	-1.31278713572453	6.90546256902651e-39	M2_vs_M1	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	SLC2A1
ENSG00000270426	ENSG00000270426	-1.00082114300966	0.00871308796545086	M2_vs_M1	HSALNG0039018	sense	Q90	NA	NA	IRF2	IPO13
ENSG00000283633	ENSG00000283633	1.37876984145457	2.71075836103395e-6	M2_vs_M1	HSALNG0133812	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6784-5p	-	IL17RA	BLZF1
ENSG00000257354	MIRLET7IHG	-1.44875942816384	9.48847737971995e-12	M2_vs_M1	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	PRRC2C
ENSG00000257514	ENSG00000257514	3.53919545999196	0.00559964414350362	M2_vs_M1	HSALNG0093518	anti_sense	Q50	NA	-	SYCP3	CASP8AP2
ENSG00000289725	ENSG00000289725	3.24683216322545	8.9567318379122e-4	M2_vs_M1	HSALNG0071598	integenic	Not conserved	NA	NA	ZNG1E	MED28
ENSG00000235381	ENSG00000235381	1.30405433428831	0.015867100134896	M2_vs_M1	HSALNG0054500	anti_sense,sense	Q90	NA	-	TFB1M	ECRG4
ENSG00000232485	RPL37A-DT	1.44826976015037	2.61934940556457e-5	M2_vs_M1	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	ALDH6A1
ENSG00000271926	ENSG00000271926	2.83123181305431	2.22339202250226e-9	M2_vs_M1	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	NRDE2
ENSG00000259590	LINC02244	1.22701722337226	7.03153772485077e-39	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	IDE
ENSG00000291049	FAM86B3P	1.20488710098574	1.6774846534884e-4	M2_vs_M1	NA	NA	NA	NA	NA	ZNF705B	EXOSC8
ENSG00000287265	ENSG00000287265	-1.47429069903334	0.00118350501065631	M2_vs_M1	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	FAM53C
ENSG00000228022	HCG20	-5.41473300598073	0.00980754026435509	M2_vs_M1	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ZFP30
ENSG00000253123	ENSG00000253123	1.3602914779787	4.46499232552255e-53	M2_vs_M1	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2	TMPO
ENSG00000290427	ENSG00000290427	1.55572868176369	1.55298798232692e-21	M2_vs_M1	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	RDH10
ENSG00000237525	ENSG00000237525	5.42985591641685	1.6877345573724094e-23	M2_vs_M1	HSALNG0022085	integenic	Q50	NA	-	ATIC	RDH10
ENSG00000274265	ENSG00000274265	-2.85391981810014	0.00227106474019111	M2_vs_M1	HSALNG0141909	integenic	Not conserved	hsa-miR-885-3p	-	PDE4DIP	SPOP
ENSG00000259673	IQCH-AS1	1.23488679635014	2.31293832470515e-6	M2_vs_M1	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB	PLBD1
ENSG00000266835	GAPLINC	2.83668404664657	1.40880513335657e-44	M2_vs_M1	HSALNG0119710	sense	Not conserved	NA	Pr interval,Citrulline measurement,-	TGIF1	PILRB
ENSG00000230107	ENSG00000230107	-2.69499150759056	9.61084416810355e-8	M2_vs_M1	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	HNRNPA2B1
ENSG00000171889	MIR31HG	2.54311347397123	0.00103631949841987	M2_vs_M1	HSALNG0070362	anti_sense,sense	Q50	hsa-miR-4483,hsa-miR-6089,hsa-miR-7151-5p	Aging,High density lipoprotein cholesterol measurement,Coagulation factor v measurement,Susceptibility to shingles measurement,Thyroid preparation use measurement,Hypothyroidism,Autoimmune disease; Hypothyroidism; Thyroid preparation use measurement,Amblyopia,Macula measurement,Autoimmune thyroid disease,-	IFNE	WIPF3
ENSG00000273179	ENSG00000273179	1.59682404166466	0.00748213061286555	M2_vs_M1	HSALNG0032247	anti_sense	Not conserved	hsa-miR-23a-5p	NA	MAEA	GLIPR2
ENSG00000225434	LINC01504	1.83126663624505	2.69186813685508e-24	M2_vs_M1	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA	CALD1
ENSG00000237638	LINC02245	1.78164191487576	1.07162881448302e-22	M2_vs_M1	HSALNG0015516	integenic	Not conserved	NA	NA	RAB1A	RBM19
ENSG00000237989	LINC01679	-3.29097077865404	0.0065301252133083	M2_vs_M1	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1	RNF11
ENSG00000254054	ENSG00000254054	6.09185540756954	1.37912133875701e-16	M2_vs_M1	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	SNAI1
ENSG00000223901	ENSG00000223901	-2.55259993063852	2.1442995114558695e-11	M2_vs_M1	HSALNG0133720	anti_sense	Q50	NA	-	YBEY	NEURL2
ENSG00000288928	ENSG00000288928	2.01411827210747	0.00342859222615398	M2_vs_M1	NA	NA	NA	NA	NA	HIF1A	RIOK1
ENSG00000266709	ENSG00000266709	-4.63790423154045	3.57293833198174e-37	M2_vs_M1	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	SYMPK
ENSG00000286504	ENSG00000286504	-6.02389350068372	4.4819007150915e-4	M2_vs_M1	HSALNG0089056	integenic	Not conserved	NA	NA	FAM90A1	GZF1
ENSG00000284543	LINC01226	3.20643804084828	0.0387441109298234	M2_vs_M1	HSALNG0002236	sense	Q75	hsa-miR-1231,hsa-miR-1207-5p,hsa-miR-4434	Intelligence,-	TINAGL1	TRAP1
ENSG00000291040	CD99P1	2.92565411108636	6.23592488203697e-23	M2_vs_M1	HSALNG0136380	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	CD99	UXT
ENSG00000206337	HCP5	-1.3269247270002	5.783265781680338e-69	M2_vs_M1	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	LRRC61
ENSG00000285966	ENSG00000285966	-3.31884293104217	4.35882620273087e-5	M2_vs_M1	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL	HP1BP3
ENSG00000287809	ENSG00000287809	2.79296501161241	0.00956282033142718	M2_vs_M1	HSALNG0110117	anti_sense,sense	Not conserved	NA	Velopharyngeal dysfunction,Adolescent idiopathic scoliosis,Empathy measurement,Unipolar depression,Major depressive disorder; Unipolar depression,Balding measurement,Inflammatory biomarker measurement; Ykl40 measurement,Bipolar disorder; Unipolar depression; Disease recurrence,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	METTL9	GNG11
ENSG00000282851	BISPR	-1.10037479581147	2.97755153935183e-13	M2_vs_M1	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	ZFP36
ENSG00000256967	ENSG00000256967	-3.64772152800638	4.03810186899063e-12	M2_vs_M1	HSALNG0088974	anti_sense	Q50	hsa-miR-146b-3p	-	RBP5	ADORA2A
ENSG00000231574	LINC02015	-3.97729751799466	8.338585494059691e-9	M2_vs_M1	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	ADORA2A
ENSG00000291097	HLA-L	-1.6951657912565	1.78970858871772e-16	M2_vs_M1	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	APOL2
ENSG00000270607	NAV2-AS6	-1.76176222083038	4.0644574390214e-4	M2_vs_M1	HSALNG0083062	anti_sense	Q75	NA	-	DBX1	APOBEC3A
ENSG00000233384	CNIH3-AS2	2.03613182565348	1.37531783346314e-10	M2_vs_M1	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	MKLN1
ENSG00000287494	ENSG00000287494	1.34742587974395	0.00619903500986143	M2_vs_M1	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	TTBK2
ENSG00000289127	ENSG00000289127	4.81200722437847	6.35286888051976e-8	M2_vs_M1	HSALNG0137342	integenic	Q90	NA	NA	MID1IP1	RHBDF2
ENSG00000262468	LINC01569	-1.12147877623425	4.45723029184428e-6	M2_vs_M1	HSALNG0109218	integenic	Q50	hsa-miR-1233-5p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-1273h-5p	Pulse pressure measurement; Central corneal thickness,Electrocardiography; Alkaline phosphatase measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Red blood cell density measurement; Erythrocyte count,Pulse pressure measurement,Alkaline phosphatase measurement,Mean reticulocyte volume	SRL	PHF10
ENSG00000231528	FAM225A	-3.6747611120341	1.81434138412869e-32	M2_vs_M1	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	CDC16
ENSG00000229771	ENSG00000229771	3.09110608802105	6.59909067782017e-63	M2_vs_M1	HSALNG0130126	integenic	Q90	NA	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement	MAFB	PGLS
ENSG00000271086	NAMA	3.22368097121173	0.00245770654114794	M2_vs_M1	HSALNG0073233	integenic	Q75	hsa-miR-892b,hsa-miR-4279,hsa-miR-4638-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6504-5p,hsa-miR-6830-5p,hsa-miR-8485	Callous-unemotional behaviour; Body mass index,Mathematical ability,-	ALG2	LSM7
ENSG00000289587	ENSG00000289587	3.37448639854816	0.0130181811040393	M2_vs_M1	HSALNG0118245	anti_sense	Q50	NA	Post-traumatic stress disorder	APOH	OSBPL2
ENSG00000260256	ENSG00000260256	-2.81803248570418	2.93553731637854e-9	M2_vs_M1	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	SHFL
ENSG00000279277	ENSG00000279277	-1.18478720011752	6.439434619301e-4	M2_vs_M1	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	ACSS2
ENSG00000287024	ENSG00000287024	2.59966894646634	0.0123909519502227	M2_vs_M1	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p	NA	APLN	ZNF428
ENSG00000232912	RERE-AS1	-2.98507110733538	5.10350162776783e-8	M2_vs_M1	HSALNG0000636	anti_sense	Q50	hsa-miR-920,hsa-miR-4447,hsa-miR-4505	Self reported educational attainment,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Thyroid peroxidase antibody measurement; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Diastolic blood pressure; Depressive symptom measurement; Basophil count; Unipolar depression; Smoking status measurement; Eosinophil count; Vitiligo,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Tourette syndrome; Aspartate aminotransferase measurement,Body fat percentage,Cup-to-disc ratio measurement; Systolic blood pressure,Open-angle glaucoma,Autism spectrum disorder,Self reported educational attainment; Intelligence,Wellbeing measurement,-	SLC45A1	ACAP3
ENSG00000245573	BDNF-AS	1.57996828835148	1.22686145940564e-5	M2_vs_M1	HSALNG0083312	integenic	Not conserved	NA	NA	BBOX1	ZNF304
ENSG00000272463	ENSG00000272463	-2.54139420195276	5.0311682178127e-4	M2_vs_M1	HSALNG0047304	integenic	Q50	NA	-	EXOC2	UNK
ENSG00000245025	ENSG00000245025	-1.45741472679832	8.81931524017839e-6	M2_vs_M1	HSALNG0063952	anti_sense	Not conserved	hsa-miR-6805-5p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Renal cell carcinoma,Basal cell carcinoma,-	PEBP4	EIF5A
ENSG00000227531	ENSG00000227531	-2.32799162097693	5.950154582378e-4	M2_vs_M1	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	RHBG
ENSG00000232093	DCST1-AS1	1.78599582138646	0.0226769062489257	M2_vs_M1	HSALNG0007463	anti_sense	Q50	hsa-miR-1207-5p	Calcium measurement; Serum urea measurement; Serum albumin measurement,Hba1c measurement,Dna methylation,Serum gamma-glutamyl transferase measurement; Urate measurement,Forehead morphology measurement,Bmi-adjusted hip circumference,Blood protein measurement; Smoking status measurement,Skin neoplasm,Gait measurement,Eosinophil percentage of leukocytes,Varicose veins; Chin morphology measurement; Cortical surface area measurement; Mosquito bite reaction size measurement; Facial morphology measurement; Serum albumin measurement; Risk-taking behaviour,Attention deficit hyperactivity disorder; Systemic lupus erythematosus; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,-	DCST2	TOE1
ENSG00000227392	HPN-AS1	-7.36096179799339	2.4610655710307903e-9	M2_vs_M1	HSALNG0125567	anti_sense	Not conserved	NA	NA	LGI4	STARD13
ENSG00000261596	ENSG00000261596	-1.20164357122468	2.5799901304748797e-12	M2_vs_M1	HSALNG0110129	sense	Q75	NA	-	METTL9	EPHB2
ENSG00000260997	ENSG00000260997	-6.71908914202135	2.4169997751919492e-144	M2_vs_M1	NA	NA	NA	NA	NA	MYO1G	CMPK2
ENSG00000227502	MROCKI	-3.57652962022884	3.65194021905277e-25	M2_vs_M1	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	SOX5
ENSG00000250777	ENSG00000250777	1.69833011967816	0.00280353525866552	M2_vs_M1	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	PUM1
ENSG00000280832	GSEC	-2.13817912092249	3.34181760882439e-7	M2_vs_M1	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	SPOCD1
ENSG00000275278	ENSG00000275278	3.51822578644883	0.0107181817641429	M2_vs_M1	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	DMTF1
ENSG00000237943	PRKCQ-AS1	-1.36765329316291	0.0120123864087745	M2_vs_M1	HSALNG0075966	integenic	Q50	hsa-miR-30b-3p,hsa-miR-891a-3p,hsa-miR-4632-3p,hsa-miR-6763-5p	Atopic asthma,Eosinophil count,Eczema; Respiratory system disease,Eosinophil percentage of leukocytes,Eczema; Allergic rhinitis,-	PFKFB3	PNPLA8
ENSG00000253522	MIR3142HG	-1.71412047700889	7.173884805947099e-118	M2_vs_M1	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	STX11
ENSG00000272081	FCHO2-DT	2.81899641824482	2.07999581081812e-22	M2_vs_M1	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	TMBIM1
ENSG00000288700	ENSG00000288700	3.23953284205884	3.82873146893863e-12	M2_vs_M1	HSALNG0147628	intronic_sense	Q50	NA	NA	CEP63	VILL
ENSG00000260565	ERVK13-1	1.02712654420212	2.34527885679127e-21	M2_vs_M1	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27	TBC1D4
ENSG00000234883	MIR155HG	-1.73850091542893	2.1806188246289997e-27	M2_vs_M1	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	HUS1
ENSG00000203446	SUGCT-AS1	-1.06463618496411	3.07470718153512e-15	M2_vs_M1	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	SLC31A1
ENSG00000279278	ENSG00000279278	2.29596823645558	7.9390449686347e-19	M2_vs_M1	HSALNG0134311	integenic	Not conserved	hsa-miR-198,hsa-miR-210-5p	NA	VPREB1	GMPR
ENSG00000230647	ENSG00000230647	-8.02441028257701	3.76526601371926e-14	M2_vs_M1	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	YAP1
ENSG00000188825	LINC00910	1.16199838870175	0.00153832261673085	M2_vs_M1	HSALNG0116632	integenic	Not conserved	NA	-	CCDC200	ALKBH8
ENSG00000255521	CD44-DT	-2.73410011836046	2.65632609329451e-5	M2_vs_M1	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	FNBP1L
ENSG00000273314	ENSG00000273314	-2.73057438253219	2.246982471567e-6	M2_vs_M1	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	DNASE2B
ENSG00000284240	LINC02801	2.5898625101829	0.0206306927309118	M2_vs_M1	HSALNG0004954	integenic	Q90	hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6085	Eosinophil count,Loneliness measurement,Basophil count,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Insomnia measurement,-	NA	CEP55
ENSG00000236901	MIR600HG	1.04448424733664	3.75327312312095e-10	M2_vs_M1	HSALNG0074272	sense	Not conserved	NA	-	STRBP	ENTPD1
ENSG00000232956	SNHG15	-1.47077143119274	9.060506453129707e-31	M2_vs_M1	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	ATIC
ENSG00000289564	ENSG00000289564	2.87345808490027	0.0109360662668214	M2_vs_M1	HSALNG0134258	anti_sense	Not conserved	hsa-miR-619-5p	NA	PPIL2	SMARCAL1
ENSG00000263718	SEPTIN9-DT	1.55588437617013	0.00140478684385612	M2_vs_M1	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2	BARD1
ENSG00000273824	ENSG00000273824	-6.789821633573	1.97144484144845e-32	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	CHRNA1
ENSG00000166770	ZNF667-AS1	1.25000236006585	0.00112073783169185	M2_vs_M1	HSALNG0127764	anti_sense	Not conserved	hsa-miR-6895-5p	Alkaline phosphatase measurement; Low density lipoprotein cholesterol measurement,-	ZNF471	GLCE
ENSG00000258521	ENSG00000258521	-2.79289608344779	3.71856787946332e-25	M2_vs_M1	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	MTTP
ENSG00000260528	FAM157C	-3.46736909473348	3.6213096411994e-4	M2_vs_M1	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8	SHISAL1
ENSG00000274565	ENSG00000274565	3.0012952917554	2.3512741772241e-4	M2_vs_M1	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	ERP27
ENSG00000189238	LINC00943	-1.92569322358757	0.00496100622928144	M2_vs_M1	HSALNG0094963	integenic	Q50	hsa-miR-619-5p,hsa-miR-936,hsa-miR-4725-3p	NA	TMEM132B	ETV6
ENSG00000287263	ENSG00000287263	-1.99397168079714	2.6627031212114497e-60	M2_vs_M1	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	C1RL
ENSG00000256442	ENSG00000256442	-4.89898938912728	0.0456461219272614	M2_vs_M1	HSALNG0089163	integenic	Not conserved	hsa-miR-6515-5p	NA	KLRB1	SMARCC2
ENSG00000290441	ENSG00000290441	-5.70674220977602	0.0022924395001149	M2_vs_M1	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	ZNF740
ENSG00000286972	ENSG00000286972	3.40275044062078	1.44863677080267e-14	M2_vs_M1	HSALNG0146843	integenic	Q90	NA	Abnormal paneth cell measurement,-	TOP1	JDP2
ENSG00000258689	LINC01269	3.45769383029705	3.8655301391392414e-9	M2_vs_M1	HSALNG0102232	integenic	Q50	hsa-miR-4309,hsa-miR-4478	-	TTC9	SLC24A4
ENSG00000285744	ENSG00000285744	-5.77294762920894	4.3953890572327097e-141	M2_vs_M1	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	WARS1
ENSG00000274536	MIR223HG	1.87086139259882	5.0925852727454e-5	M2_vs_M1	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH	LINS1
ENSG00000269220	LINC00528	-2.36773989741132	2.52544018884524e-6	M2_vs_M1	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	GAS8
ENSG00000290385	ENSG00000290385	-2.26254203415436	0.00577527270476731	M2_vs_M1	HSALNG0000017	integenic	Not conserved	NA	NA	OR4F29	TOM1L1
ENSG00000281392	LINC00506	-3.3629542799725	0.00370936762760305	M2_vs_M1	HSALNG0027226	integenic	Not conserved	NA	Prostate carcinoma,-	CHMP2B	SGSM2
ENSG00000263345	SGSM2-AS1	1.05027084361852	0.0087913266379778	M2_vs_M1	HSALNG0113905	anti_sense	Q75	hsa-miR-4313,hsa-miR-6132	Self reported educational attainment; Autism spectrum disorder,Lifestyle measurement,-,Household income	MNT	GNAL
ENSG00000226822	LINC02785	1.86333309432706	7.332241698954022e-14	M2_vs_M1	HSALNG0005787	anti_sense	Q50	hsa-miR-1224-5p,hsa-miR-4508,hsa-miR-4638-3p,hsa-miR-6089	Bipolar disorder,Neutrophil count,Waist-hip ratio,Heel bone mineral density,Hba1c measurement,Hemoglobin a1 measurement,Mean corpuscular volume,Covid-19,Growth-regulated alpha protein measurement,Herpes zoster,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Forced expiratory volume; Response to bronchodilator,-	NBPF6	SLC39A6
ENSG00000286757	ENSG00000286757	1.21774850512247	0.0207187533068983	M2_vs_M1	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5	RPTOR
ENSG00000290727	ALMS1P1	-5.95029395365293	6.2776554116408e-4	M2_vs_M1	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	CBX4
ENSG00000253671	ENSG00000253671	1.12412790785695	1.4286612937318e-4	M2_vs_M1	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	ZCCHC2
ENSG00000269982	ENSG00000269982	1.21559586647772	4.04587118324584e-6	M2_vs_M1	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	IFNAR1
ENSG00000255801	ENSG00000255801	-6.1592469433431	1.2735150412101e-4	M2_vs_M1	HSALNG0089073	integenic	Not conserved	NA	Takayasu arteritis,Response to radiation	CLEC4E	PTPRF
ENSG00000290095	ENSG00000290095	2.9956198357307	0.00816742774421067	M2_vs_M1	NA	NA	NA	NA	NA	GALNTL5	IGSF3
ENSG00000237886	NALT1	1.97845940443157	0.013690446936246	M2_vs_M1	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7	C1orf162
ENSG00000274508	ENSG00000274508	-2.3169238046147	8.03517216050965e-5	M2_vs_M1	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	CGN
ENSG00000285632	ENSG00000285632	1.90343474588095	0.0310443742729243	M2_vs_M1	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5	HAX1
ENSG00000246250	ENSG00000246250	-1.65230793389229	0.0353637603656537	M2_vs_M1	HSALNG0083840	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4487	Body mass index,Chronotype measurement,-	ALX4	C1orf35
ENSG00000286872	ENSG00000286872	2.74274726236726	4.85204855118027e-50	M2_vs_M1	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	ETNK2
ENSG00000291114	SIGLEC17P	1.67153203898349	1.0731728796031402e-15	M2_vs_M1	NA	NA	NA	NA	NA	SIGLEC7	RALB
ENSG00000256196	ENSG00000256196	-1.78066164286995	0.0468901535915789	M2_vs_M1	HSALNG0084483	anti_sense	Q50	hsa-miR-3155b	Blood protein measurement,-	PRPF19	TAMM41
ENSG00000257127	CLLU1	-4.64505342280567	1.67726328986392e-7	M2_vs_M1	HSALNG0093062	anti_sense	Q50	NA	Methionine measurement,Sudden cardiac arrest,-	PLEKHG7	TAMM41
ENSG00000283648	ENSG00000283648	-7.01298778004042	2.61143952330235e-7	M2_vs_M1	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	ITGA9
ENSG00000288961	ENSG00000288961	-1.53356446339938	6.57737417438398e-6	M2_vs_M1	HSALNG0116727	integenic	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4508,hsa-miR-6816-5p	-	RUNDC3A	GOLGA4
ENSG00000286548	ENSG00000286548	-2.36280870103347	1.34936063923269e-10	M2_vs_M1	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	PLA1A
ENSG00000232295	ENSG00000232295	-1.00516801255639	0.0333847971022545	M2_vs_M1	HSALNG0051162	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Antipsychotic drug related weight gain; Longitudinal bmi measurement,Beta-amyloid 1-42 measurement,Heel bone mineral density,Lung carcinoma,Body height,-	B3GAT2	SPATA9
ENSG00000235823	OLMALINC	-1.12764661772052	3.07427180670811e-6	M2_vs_M1	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	GFOD1
ENSG00000236841	ENSG00000236841	3.38203683290971	0.0145907601279364	M2_vs_M1	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	TBC1D32
ENSG00000291173	CASP4LP	-3.06559564339332	1.37350078453669e-5	M2_vs_M1	NA	NA	NA	NA	NA	CASP12	ATXN7L1
ENSG00000250929	LINC01181	-3.02984468340032	9.10481404620856e-60	M2_vs_M1	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	TMEM140
ENSG00000291143	ENSG00000291143	-2.31602440517395	1.88282370905293e-19	M2_vs_M1	NA	NA	NA	NA	NA	OR2AG2	TLK2
ENSG00000290867	LINC01145	-1.79455122578218	1.95114247870101e-5	M2_vs_M1	HSALNG0142314	integenic	Not conserved	NA	-	PPIAL4D	NONO
ENSG00000289844	ENSG00000289844	-5.30063181321078	0.0145217466378547	M2_vs_M1	HSALNG0102515	integenic	Q75	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089,hsa-miR-6769a-3p	Periodontitis,Basophil count; Basophil percentage of leukocytes,Total blood protein measurement,-	FOS	LPAR4
ENSG00000289092	ENSG00000289092	-2.09633365007722	2.5909916247041502e-9	M2_vs_M1	HSALNG0077924	anti_sense	Not conserved	hsa-miR-1273h-5p	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Erythrocyte count	TIMM23	ZNF185
ENSG00000204832	ST8SIA6-AS1	5.51885528313187	2.09017758865909e-13	M2_vs_M1	HSALNG0076446	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6764-5p	Sleep apnea measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement,Aspartate aminotransferase measurement,-	VIM	ST8SIA6
ENSG00000183250	LINC01547	-1.26437923917337	6.674221544571621e-9	M2_vs_M1	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2	CAMK2G
ENSG00000290866	OTOAP1	3.71387035354263	4.96181475378688e-22	M2_vs_M1	NA	NA	NA	NA	NA	NPIPB5	CWC15
ENSG00000249685	ENSG00000249685	-1.6500093492496	3.0531931199122e-4	M2_vs_M1	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	PIH1D2
ENSG00000225963	ENSG00000225963	-1.62579375349442	2.11167078918699e-5	M2_vs_M1	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	TWF1
ENSG00000223949	ROR1-AS1	2.41416100051875	7.63114693909117e-93	M2_vs_M1	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	DIP2C
ENSG00000219665	ZNF433-AS1	2.16142313458384	2.3118171717988e-15	M2_vs_M1	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA	FHIP2A
ENSG00000249502	MED28-DT	-2.83907416699416	2.1982284830819e-33	M2_vs_M1	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	MMAA
ENSG00000249825	THBS4-AS1	3.45080109673042	1.85834646092859e-15	M2_vs_M1	HSALNG0042960	anti_sense	Q90	hsa-miR-4447	Corneal topography,Intraocular pressure measurement,-,Thyroid stimulating hormone measurement; Abnormality of refraction	SERINC5	TMEM45B
ENSG00000229400	CNIH3-AS1	-4.69991095600772	1.8104551086557e-13	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	WWC2
ENSG00000226004	LINC02528	-9.40928492112451	3.89762393268571e-39	M2_vs_M1	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	PSTPIP2
ENSG00000230838	LINC01614	5.20131570597662	1.2483738974324098e-45	M2_vs_M1	HSALNG0022084	integenic	Q50	NA	Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169	PDE3B
ENSG00000226067	LINC00623	-2.16183951606901	8.99793272219987e-7	M2_vs_M1	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	CCDC50
ENSG00000273226	ENSG00000273226	3.05239070762049	4.65976207759032e-9	M2_vs_M1	HSALNG0070293	anti_sense	Not conserved	NA	NA	DENND4C	PFKM
ENSG00000253217	ENSG00000253217	1.32483359306424	0.0306031041883462	M2_vs_M1	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	TEX29
ENSG00000278869	ENSG00000278869	-1.26014860395032	0.0142943102311895	M2_vs_M1	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12	CD8A
ENSG00000253154	ENSG00000253154	2.06178628855212	4.4022156214279e-7	M2_vs_M1	HSALNG0066721	integenic	Q50	hsa-miR-4463,hsa-miR-8485	Chronotype measurement,-	ATP6V0D2	CNKSR3
ENSG00000224397	PELATON	1.07947690359001	1.9768560001883194e-42	M2_vs_M1	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	TRIP12
ENSG00000260193	LINC02846	1.32499088929952	0.00241112649831076	M2_vs_M1	HSALNG0075219	integenic	Q50	hsa-miR-6858-3p	NA	TMEM250	LY96
ENSG00000259321	ENSG00000259321	-2.26236205763033	0.00324276884117944	M2_vs_M1	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	BTG3
ENSG00000289080	ENSG00000289080	2.03026010362291	9.4008502783041e-4	M2_vs_M1	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	RABEP2	C21orf91
ENSG00000233175	FMNL1-AS1	-2.54746695157237	0.0373258618847122	M2_vs_M1	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32	USP43
ENSG00000287074	ENSG00000287074	2.35530709517427	0.0415236567568368	M2_vs_M1	HSALNG0143356	sense	Not conserved	NA	NA	AEBP2	FBXL18
ENSG00000278330	ENSG00000278330	1.38841541865319	2.90009180187859e-6	M2_vs_M1	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	HEATR3
ENSG00000275120	ENSG00000275120	2.03445839146311	0.0326929216922225	M2_vs_M1	HSALNG0107802	integenic	Not conserved	NA	NA	WDR73	GNAQ
ENSG00000286546	ENSG00000286546	3.24198190342901	7.28552619176282e-20	M2_vs_M1	HSALNG0128824	anti_sense	Not conserved	NA	Cognitive impairment measurement,High density lipoprotein cholesterol measurement; Response to diuretic,-	KIF16B	DRAM2
ENSG00000274370	ENSG00000274370	2.37820164084741	9.15964116929254e-6	M2_vs_M1	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	HKDC1
ENSG00000233613	DCUN1D2-AS	2.74329168848235	0.0339527292746299	M2_vs_M1	HSALNG0099596	anti_sense	Not conserved	NA	Neutrophil count; Monocyte percentage of leukocytes,-	TMCO3	NPTN
ENSG00000284882	ENSG00000284882	1.00087427052671	6.33116538810845e-6	M2_vs_M1	HSALNG0004813	anti_sense	Q50	NA	-	SPATA1	EXOG
ENSG00000289161	ENSG00000289161	-1.36092869436048	5.78063351857368e-13	M2_vs_M1	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	FCHO2
ENSG00000224186	PITX1-AS1	1.3868016050059	6.82408315633954e-5	M2_vs_M1	HSALNG0045024	integenic	Not conserved	NA	NA	CATSPER3	NECAP2
ENSG00000271643	PDCD6IP-DT	-1.4557924286154	4.526724107993731e-9	M2_vs_M1	HSALNG0025078	anti_sense	Not conserved	NA	-	CLASP2	ST3GAL2
ENSG00000261971	MMP25-AS1	-4.04039114248855	3.51383791948853e-59	M2_vs_M1	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	KCNJ15
ENSG00000287415	ENSG00000287415	4.59769471857596	8.95097371331254e-16	M2_vs_M1	HSALNG0025355	integenic	Q50	hsa-miR-8485	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,Heel bone mineral density,Hip bone mineral density,Testosterone measurement; Systolic blood pressure,Testosterone measurement,Hypermetropia; Bone density; Myopia,Bone density,Femoral neck bone mineral density; Bone fracture,Bone density; Heel bone mineral density,Drugs affecting bone structure and mineralization use measurement,Femoral neck bone mineral density; Spine bone mineral density,Osteoporosis,Lean body mass; Bone density,Adolescent idiopathic scoliosis,Systolic blood pressure,Myopia,Mean arterial pressure,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Response to amisulpride; Longitudinal bmi measurement,Refractive error,-	ZNF621	LCA5L
ENSG00000234456	MAGI2-AS3	-2.7935191529083	1.10575660911229e-48	M2_vs_M1	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	C2CD2
ENSG00000273472	ENSG00000273472	-2.54099621129409	4.62243553949523e-39	M2_vs_M1	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	ACAN
ENSG00000226328	NUP50-DT	-1.06439067627977	2.57330170598331e-16	M2_vs_M1	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	SPATA2
ENSG00000226441	PLCL2-AS1	3.55902131490995	0.00802418586795658	M2_vs_M1	HSALNG0024502	anti_sense	Q75	NA	NA	TBC1D5	ZC3H18
ENSG00000260260	SNHG19	1.11006007523174	0.0213703395570637	M2_vs_M1	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	SON
ENSG00000125462	MIR9-1HG	-5.57808510172262	2.51811163021753e-16	M2_vs_M1	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	CLIC6
ENSG00000267026	ENSG00000267026	2.01411432689008	0.00369716273277265	M2_vs_M1	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	MED8
ENSG00000272172	ENSG00000272172	2.77443477758182	0.0452380465624239	M2_vs_M1	HSALNG0069270	anti_sense	Not conserved	hsa-miR-3960	Body height,-	TOP1MT	ACE
ENSG00000272129	ENSG00000272129	2.67283715759816	0.0197102892451092	M2_vs_M1	HSALNG0051481	integenic	Q50	NA	NA	BCKDHB	SPON2
ENSG00000246528	SLCO5A1-AS1	-5.61548456757848	0.00432311854038507	M2_vs_M1	HSALNG0066029	anti_sense	Q50	NA	Leukocyte count; Neutrophil count,Diverticular disease,Response to cetuximab; Skin disease,-	SULF1	CTBP1
ENSG00000243089	ENSG00000243089	-3.92588245597867	2.43517287265088e-8	M2_vs_M1	HSALNG0027523	integenic	Q50	NA	Bmi-adjusted waist circumference; Optic cup area measurement,Serum alanine aminotransferase measurement,Precuneus cortex volume measurement,Optic cup area measurement; Optic disc size measurement,Cup-to-disc ratio measurement,Rr interval,Optic disc area measurement,Liver fibrosis measurement,Susceptibility to childhood ear infection measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Chronic kidney disease,Body height,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Cup-to-disc ratio measurement; Optic cup area measurement,-	FILIP1L	NDUFV3
ENSG00000230555	LINC02916	1.08256028929088	0.0154375542964481	M2_vs_M1	HSALNG0077549	integenic	Q50	hsa-miR-619-5p	NA	ZNF487	VAV2
ENSG00000272669	ENSG00000272669	-1.51602003608449	3.6776159923109e-4	M2_vs_M1	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	CD3G
ENSG00000286129	ENSG00000286129	1.32268839169786	0.0055335833040599	M2_vs_M1	HSALNG0134321	integenic	Not conserved	NA	-	VPREB1	IL6R
ENSG00000273032	DGCR5	5.77038000942237	1.02331445295436e-15	M2_vs_M1	HSALNG0133984	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-764	NA	FAM246C	SH2B2
ENSG00000234147	ENSG00000234147	3.58147529146861	2.93390112702474e-8	M2_vs_M1	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	SYVN1
ENSG00000272335	ENSG00000272335	1.17167662314547	1.0241668565265e-6	M2_vs_M1	HSALNG0041565	integenic	Not conserved	NA	-	MRPS30	SLC45A1
ENSG00000289589	ENSG00000289589	-6.28288200964985	6.69357984541394e-5	M2_vs_M1	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	DHRS3
ENSG00000272449	ENSG00000272449	-1.10878044671023	3.35954706595047e-11	M2_vs_M1	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	PEA15
ENSG00000267712	LINC01539	-6.77892093209695	7.15503864909407e-6	M2_vs_M1	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	FCAMR
ENSG00000258768	ENSG00000258768	2.19905888730611	0.00189693147474607	M2_vs_M1	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5	FBXO41
ENSG00000258018	LINC02457	1.68601507058015	5.01047571660675e-10	M2_vs_M1	HSALNG0094325	integenic	Not conserved	NA	NA	MAP1LC3B2	SLC22A15
ENSG00000255363	LINC02757	-2.40353314135796	2.4857779418112e-5	M2_vs_M1	HSALNG0085868	integenic	Not conserved	hsa-miR-4710	NA	LRRC32	CCT3
ENSG00000272555	ENSG00000272555	1.06301702482746	0.0143952752776042	M2_vs_M1	HSALNG0022299	integenic	Not conserved	NA	NA	CYP27A1	CWC22
ENSG00000287691	ENSG00000287691	-2.4854806089741	7.20020309180749e-5	M2_vs_M1	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	PYHIN1
ENSG00000224995	LINC01526	2.40776109568314	4.61377189798665e-6	M2_vs_M1	HSALNG0051540	integenic	Q75	hsa-miR-761,hsa-miR-3619-5p,hsa-miR-6132	Loneliness measurement,Basophil count; Basophil percentage of leukocytes; Monocyte percentage of leukocytes,Coronary artery disease,Bmi-adjusted waist circumference,Cognitive function measurement,Body height,Myocardial infarction,Central corneal thickness,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,Basophil count; Basophil percentage of leukocytes,Monocyte percentage of leukocytes,Central corneal thickness; Intraocular pressure measurement,Corneal resistance factor; Intraocular pressure measurement,Central corneal thickness; Corneal topography,Obsessive-compulsive disorder; Sex interaction measurement,Heel bone mineral density,-	TENT5A	RPL22L1
ENSG00000231808	LINC01388	-1.48456208688999	6.1672110315701e-4	M2_vs_M1	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	RYBP
ENSG00000267272	LINC01140	1.08755115612485	0.0261839637643058	M2_vs_M1	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	CRELD1
ENSG00000272145	NFYC-AS1	-1.64367614253071	0.01693076336514	M2_vs_M1	HSALNG0002891	anti_sense	Q90	hsa-miR-661,hsa-miR-4447,hsa-miR-4761-3p,hsa-miR-8072	Body height,-	RIMS3	POLR2H
ENSG00000231672	DIRC3	1.80773595643286	4.48695747413195e-6	M2_vs_M1	HSALNG0022200	integenic	Not conserved	NA	NA	TNS1	ANAPC10
ENSG00000261036	ENSG00000261036	2.18335976993187	0.00253959060619347	M2_vs_M1	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	ADGRV1
ENSG00000286174	ENSG00000286174	-5.08934769465179	1.13644363756407e-28	M2_vs_M1	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	ANKRD33B
ENSG00000273002	ARHGEF2-AS2	-1.52495362294612	3.5050097167541103e-9	M2_vs_M1	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	CSF2
ENSG00000254338	MAFA-AS1	4.63290158007104	6.32113776569553e-10	M2_vs_M1	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	CREBRF
ENSG00000235257	ITGA9-AS1	3.44354199333867	4.38797313156215e-5	M2_vs_M1	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	DAGLB
ENSG00000287839	ENSG00000287839	-2.06698700340538	2.3574904340603197e-19	M2_vs_M1	HSALNG0007520	integenic	Not conserved	NA	Neutrophil count	YY1AP1	COG5
ENSG00000250274	ENSG00000250274	-4.28203649682236	1.71574980784312e-14	M2_vs_M1	NA	NA	NA	NA	NA	LCP2	ALDH7A1
ENSG00000289070	ENSG00000289070	4.30151686716827	5.538656243398809e-31	M2_vs_M1	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	CYBB
ENSG00000214401	KANSL1-AS1	1.02155022520313	5.49558769844637e-8	M2_vs_M1	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ARHGAP12
ENSG00000243491	ENSG00000243491	3.79146251720563	8.99044516000556e-6	M2_vs_M1	HSALNG0012921	integenic	Not conserved	hsa-miR-665,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6829-5p	NA	YWHAQ	DDIAS
ENSG00000250519	ENSG00000250519	-2.674349132398	2.00753220327474e-6	M2_vs_M1	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	PRPF18
ENSG00000291178	ENSG00000291178	-1.32158767390659	0.037318199011649	M2_vs_M1	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimer’s disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1	ARHGEF40
ENSG00000260807	CEROX1	1.71844905511977	1.17288735136601e-13	M2_vs_M1	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	METTL3
ENSG00000185433	LINC00158	-6.48051518367384	1.0601541083314e-29	M2_vs_M1	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	ABTB2
ENSG00000231858	STAT4-AS1	-6.77997666502951	5.43039289749215e-7	M2_vs_M1	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS	NUDT13
ENSG00000260877	ENSG00000260877	-3.10195227864479	9.05444853131117e-16	M2_vs_M1	HSALNG0085333	integenic	Not conserved	hsa-miR-4308,hsa-miR-4447,hsa-miR-4492	NA	MYEOV	PPFIBP2
ENSG00000258791	LINC00520	1.65270015489947	8.93240450158537e-19	M2_vs_M1	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2	TMED3
ENSG00000258810	ENSG00000258810	2.26004930685814	5.84788256078509e-5	M2_vs_M1	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p	NA	RNASE6	NDEL1
ENSG00000259342	ENSG00000259342	-3.23757077227602	1.38176189759945e-13	M2_vs_M1	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM	MMP10
ENSG00000260803	ENSG00000260803	2.42945302445347	8.7940767815114e-4	M2_vs_M1	HSALNG0144829	integenic	Q75	hsa-miR-4650-5p	-	POLR3K	STX3
ENSG00000178803	ADORA2A-AS1	-7.83531530813046	2.60477027999987e-14	M2_vs_M1	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	C15orf48
ENSG00000255921	ENSG00000255921	-1.7844842183264	5.52633188676212e-7	M2_vs_M1	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	SP2
ENSG00000226950	DANCR	1.03686267063584	5.80821822076017e-6	M2_vs_M1	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	VKORC1
ENSG00000242048	PRKAG2-AS2	-2.77198381379969	1.27618026768579e-67	M2_vs_M1	HSALNG0149841	anti_sense	Not conserved	NA	NA	GALNTL5	MFSD3
ENSG00000272008	ENSG00000272008	-5.87400747247646	8.6915467450142e-4	M2_vs_M1	HSALNG0149464	anti_sense	Q75	NA	-	CGA	CD300C
ENSG00000229140	CCDC26	5.50081818017367	1.22257223797705e-62	M2_vs_M1	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	CD300A
ENSG00000269970	ENSG00000269970	1.7628091933267	7.0965556865818e-4	M2_vs_M1	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	GHDC
ENSG00000291236	ENSG00000291236	-3.29128568360524	0.00663041235691623	M2_vs_M1	NA	NA	NA	NA	NA	TNS1	FAM107A
ENSG00000285863	ENSG00000285863	-1.16522678770094	0.0113001152312874	M2_vs_M1	HSALNG0144382	anti_sense	Not conserved	NA	Fev/fec ratio,-	C2CD4A	STX18
ENSG00000255422	ENSG00000255422	2.36195348071733	6.43165134182963e-16	M2_vs_M1	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	RNF181
ENSG00000241886	ENSG00000241886	-1.50605974781692	3.87741412908836e-6	M2_vs_M1	HSALNG0137207	sense	Q90	NA	-	GK	LRRC28
ENSG00000285551	LINC02929	4.67479615348496	4.22609076529106e-7	M2_vs_M1	HSALNG0078329	sense	Q75	hsa-miR-4505,hsa-miR-1587,hsa-miR-5703	NA	NA	ENHO
ENSG00000231856	ENSG00000231856	-2.19996820298271	0.0347114277898168	M2_vs_M1	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2	SLC35G2
ENSG00000266718	ENSG00000266718	2.69869291402993	0.0450155066868043	M2_vs_M1	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	RAB3B
ENSG00000228863	ENSG00000228863	-3.05562707732301	2.0223556640499797e-11	M2_vs_M1	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7	CLIC4
ENSG00000276148	ENSG00000276148	1.92443432983984	0.0460172840296752	M2_vs_M1	HSALNG0090284	anti_sense	Q75	NA	NA	YARS2	TAPT1
ENSG00000263050	DPH1-AS1	-2.31522412203067	0.0103108856212954	M2_vs_M1	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6	HNRNPF
ENSG00000258733	LINC02328	-2.05933269569452	2.22000326063015e-8	M2_vs_M1	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	PUSL1
ENSG00000185168	LINC00482	2.83168724670589	0.00167032465888928	M2_vs_M1	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	FAXDC2
ENSG00000235478	LINC01664	4.30780724175573	2.0344652144273e-4	M2_vs_M1	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	TMED10
ENSG00000265678	ENSG00000265678	-2.5114032542083	0.00360527325140988	M2_vs_M1	HSALNG0119378	anti_sense	Q50	NA	NA	SLC16A3	KRT8
ENSG00000235215	ENSG00000235215	-3.12893724255035	0.0148168432493023	M2_vs_M1	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	METTL7B
ENSG00000234807	LINC01135	3.67078930588	5.4397969359439694e-136	M2_vs_M1	HSALNG0003956	anti_sense	Q50	hsa-miR-497-5p,hsa-miR-504-3p,hsa-miR-922,hsa-miR-3197,hsa-miR-5587-3p,hsa-miR-5787,hsa-miR-6722-3p,hsa-miR-6728-3p,hsa-miR-6829-3p,hsa-miR-6873-3p,hsa-miR-7108-3p	Aminoadipic acid measurement,Neuropsychological test,Empathy measurement,Sleep duration,-	FGGY	HOPX
ENSG00000174370	KCNJ5-AS1	2.4144891762599	1.2753458715845099e-192	M2_vs_M1	NA	NA	NA	NA	NA	TP53AIP1	PWWP2B
ENSG00000228742	LINC02577	1.87329157157428	8.0111487521286e-4	M2_vs_M1	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	MAL
ENSG00000230438	SERPINB9P1	-1.85276961561564	1.74370595588533e-50	M2_vs_M1	HSALNG0047525	integenic	Not conserved	NA	NA	SERPINB9	SLFN12
ENSG00000238045	MVP-DT	-2.74144721521923	6.6571536202653085e-34	M2_vs_M1	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	CEBPB
ENSG00000239445	ST3GAL6-AS1	1.7897929930352	1.7655680291072398e-35	M2_vs_M1	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2	AZU1
ENSG00000238164	TNFRSF14-AS1	1.29299907601797	9.1913506470707e-40	M2_vs_M1	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	AZU1
ENSG00000162888	C1orf147	-2.65217577689062	1.36144058945001e-10	M2_vs_M1	NA	NA	NA	NA	NA	EIF2D	NIPAL4
ENSG00000233975	LINC02574	-5.94992464148674	9.4832144008089e-4	M2_vs_M1	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	MUCL1
ENSG00000236700	LINC01010	1.49154963822168	4.31387194637987e-70	M2_vs_M1	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	RASGRP1
ENSG00000254554	ADM-DT	-3.88999618441137	1.0147195883128e-4	M2_vs_M1	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	WASHC2C
ENSG00000233901	LINC01503	2.03186720396249	7.1802679146676795e-19	M2_vs_M1	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA	NOC3L
ENSG00000286481	ENSG00000286481	3.82114843557301	9.15809401840508e-13	M2_vs_M1	HSALNG0018495	integenic	Not conserved	NA	NA	TSN	ABLIM3
ENSG00000287733	ENSG00000287733	-1.00676569094192	3.48372202288393e-6	M2_vs_M1	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	MFSD4B
ENSG00000258875	ENSG00000258875	-2.57607186719364	2.27328086199958e-5	M2_vs_M1	HSALNG0103182	anti_sense	Q50	hsa-miR-7155-5p	NA	DGLUCY	TRIB1
ENSG00000230061	TRPM2-AS	-1.85976797299116	0.016603963396175	M2_vs_M1	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	NABP1
ENSG00000288767	ENSG00000288767	-4.18719259153893	7.40583104172032e-10	M2_vs_M1	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	ZNF791
ENSG00000253549	CA3-AS1	1.54780699852852	1.4650421573358e-4	M2_vs_M1	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	GNG5
ENSG00000227066	ENSG00000227066	-2.69488263799207	6.006331508639e-4	M2_vs_M1	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	GTF2IRD2B
ENSG00000290394	ENSG00000290394	-2.55215961745404	0.0143137974454504	M2_vs_M1	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3	MFSD4A
ENSG00000225886	ENSG00000225886	-5.2607600247522	8.36415599555205e-22	M2_vs_M1	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	PELI3
ENSG00000251230	MIR3945HG	-5.95444892217005	4.674622932508089e-177	M2_vs_M1	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	ADGRE1
ENSG00000253773	CFAP418-AS1	3.60347186369292	1.35677112541093e-23	M2_vs_M1	HSALNG0150259	integenic	Q50	hsa-miR-3960,hsa-miR-6089,hsa-miR-8072	NA	PLEKHF2	GK5
ENSG00000205837	LINC00487	-5.68128954083971	2.64498026923302e-17	M2_vs_M1	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	RMI2
ENSG00000229931	ATXN1-AS1	1.99253471703161	4.7045561166117e-9	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	TOMM5
ENSG00000253939	ENSG00000253939	-5.30135301392968	0.00760171155583391	M2_vs_M1	HSALNG0064732	anti_sense	Q50	NA	Blood metabolite measurement	ADAM2	PLEKHD1
ENSG00000286707	ENSG00000286707	3.2420568975168	0.00108028949768049	M2_vs_M1	HSALNG0013717	anti_sense,sense	Q90	NA	Non-small cell lung carcinoma,-	SELENOI	ZNF135
ENSG00000232453	LINC02777	1.04737140537783	1.88500403255123e-10	M2_vs_M1	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	SPRYD4
ENSG00000225177	NHSL1-AS1	2.91857802334464	2.982622251934e-32	M2_vs_M1	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A	METRNL
ENSG00000289618	ENSG00000289618	2.35485500841569	0.0201864547254514	M2_vs_M1	HSALNG0112251	anti_sense,sense	Not conserved	NA	Eosinophil count,High density lipoprotein cholesterol measurement,-	DUS2	C19orf18
ENSG00000289691	ENSG00000289691	-1.0233008238251	0.0496636235282387	M2_vs_M1	HSALNG0060000	sense	Q75	hsa-miR-619-5p	-	PILRA	C19orf18
ENSG00000291086	LGALS17A	-5.96344175962639	8.05236647918709e-22	M2_vs_M1	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	SAMD9L
ENSG00000272734	ADIRF-AS1	1.35216984886242	7.16288164492638e-12	M2_vs_M1	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2	TGIF1
ENSG00000254859	ENSG00000254859	-1.40763607524099	0.00560579852238231	M2_vs_M1	HSALNG0150508	integenic	Not conserved	NA	Leukocyte count	ZC3H3	ZNF491
ENSG00000260711	ENSG00000260711	-2.94656308360515	0.0448885349312859	M2_vs_M1	HSALNG0103215	sense	Not conserved	NA	NA	CATSPERB	NDUFV2
ENSG00000224307	LINC02975	3.37771880600293	1.0060290950989599e-131	M2_vs_M1	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	MAF
ENSG00000261211	ENSG00000261211	2.08231720597677	7.046106420576801e-10	M2_vs_M1	HSALNG0047833	integenic	Q75	hsa-miR-6833-3p	Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,-	F13A1	ZNF713
ENSG00000249207	ENSG00000249207	-2.61611287422354	0.00996045374942659	M2_vs_M1	HSALNG0033933	integenic	Not conserved	hsa-miR-6090,hsa-miR-1273h-5p	NA	TMEM156	GLULP4
ENSG00000231346	LINC01160	3.27769648611032	6.02745750870014e-50	M2_vs_M1	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	THBD
ENSG00000271032	ENSG00000271032	-3.41816083778184	3.83341859854974e-21	M2_vs_M1	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	EXOC3L1
ENSG00000233818	CLDN14-AS1	2.76624603394589	6.46687477661819e-8	M2_vs_M1	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	SAMD4B
ENSG00000274461	LINC02930	4.59090642882737	3.05414680535251e-39	M2_vs_M1	HSALNG0081109	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4	PCARE
ENSG00000227917	ENSG00000227917	-2.48061205921224	0.0202175621384908	M2_vs_M1	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	PDXDC1
ENSG00000260077	ENSG00000260077	-1.17551596282621	1.1562696147382e-5	M2_vs_M1	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1	ZNF771
ENSG00000204261	PSMB8-AS1	-1.10778012202472	1.1968588667104e-4	M2_vs_M1	HSALNG0049455	anti_sense,sense	Q75	NA	Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9	FUT7
ENSG00000225783	MIAT	-2.37231750884754	6.664703897849079e-25	M2_vs_M1	HSALNG0134655	integenic	Q50	hsa-miR-216a-3p,hsa-miR-619-5p,hsa-miR-1285-5p,hsa-miR-4496,hsa-miR-4505,hsa-miR-4690-3p,hsa-miR-4726-3p,hsa-miR-5007-5p,hsa-miR-6089,hsa-miR-6754-5p,hsa-miR-6777-3p,hsa-miR-8485	Serum igg glycosylation measurement,Rr interval,Non-hodgkins lymphoma,Grey matter density measurement,Diet measurement,Gastroesophageal reflux disease,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement; Mathematical ability,Intelligence,Lysophosphatidylethanolamine 18:1 measurement,Cognition,Electroencephalogram measurement; Theta wave measurement,Parental genotype effect measurement; Peanut allergy measurement,Covid-19; Pneumonia,Hypermetropia; Myopia,-	CRYBA4	PRF1
ENSG00000288754	ENSG00000288754	1.90053646302925	2.02347697786327e-7	M2_vs_M1	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	YOD1
ENSG00000289942	ENSG00000289942	-5.17910795619205	0.0117872912021967	M2_vs_M1	NA	NA	NA	NA	NA	TMPRSS11E	OR52N4
ENSG00000276476	LINC00540	-4.72624516485118	5.487993921174611e-9	M2_vs_M1	HSALNG0143794	integenic	Q50	NA	NA	FGF9	PHLDA2
ENSG00000182376	ENSG00000182376	2.87039007628743	0.0109592895724154	M2_vs_M1	NA	NA	NA	NA	NA	CTU2	ENSG00000182376
ENSG00000230303	ENSG00000230303	2.53330274398522	0.0341312297348782	M2_vs_M1	HSALNG0072359	integenic	Not conserved	NA	Viral load,-	AGTPBP1	TTC3
ENSG00000272894	MIOS-DT	-1.85715812064189	0.0070513804918445	M2_vs_M1	HSALNG0056056	anti_sense	Not conserved	hsa-miR-5571-3p	NA	COL28A1	HMGN4
ENSG00000229337	ENSG00000229337	-1.70609139977371	0.00530200869624995	M2_vs_M1	HSALNG0146662	integenic	Not conserved	NA	NA	NFE2L2	SPATA13
ENSG00000289351	ENSG00000289351	2.39956477285766	1.3069082728196e-4	M2_vs_M1	HSALNG0028867	integenic	Not conserved	NA	NA	COPG1	SPATA13
ENSG00000271880	ENSG00000271880	1.66694500159933	0.00129254435218763	M2_vs_M1	NA	NA	NA	NA	NA	ADIRF	NPIPA5
ENSG00000241042	ENSG00000241042	-5.179303004648	0.0261866752059295	M2_vs_M1	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	ARSI
ENSG00000235513	L3MBTL2-AS1	-3.34212664385325	7.545276482475169e-31	M2_vs_M1	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	C22orf46P
ENSG00000245248	USP2-AS1	2.63584823912219	3.55804688978213e-21	M2_vs_M1	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	SEPTIN9
ENSG00000223969	ENSG00000223969	-1.32686229117076	0.0012583208171485	M2_vs_M1	HSALNG0059467	anti_sense	Q75	NA	-	FAM237B	IMMP2L
ENSG00000253837	ENSG00000253837	-2.40782312814042	0.0287970402119576	M2_vs_M1	HSALNG0063981	anti_sense	Q50	hsa-miR-4534	-	R3HCC1	DGAT1
ENSG00000243055	GK-AS1	-1.98568852286415	4.6762983418799204e-15	M2_vs_M1	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	SEMA4B
ENSG00000251323	LINC02728	-3.15869378779369	1.18778789594817e-7	M2_vs_M1	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2	FAF1
ENSG00000197536	IRF1-AS1	-3.85180106733906	6.68006295234209e-102	M2_vs_M1	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	GP1BA
ENSG00000262151	ENSG00000262151	4.81698906545296	7.48821318147944e-8	M2_vs_M1	HSALNG0109562	anti_sense	Q50	hsa-miR-149-5p,hsa-miR-619-5p,hsa-miR-4463,hsa-miR-4774-5p,hsa-miR-6728-3p	Red blood cell density measurement; Erythrocyte count,Susceptibility to chronic sinus infection measurement,Nasopharyngeal neoplasm; Bmi-adjusted waist-hip ratio; Celiac disease,Ulcerative colitis,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Serum albumin measurement,-	DEXI	FAM174B
ENSG00000260219	CD2BP2-DT	1.37383561383075	3.737487002557819e-30	M2_vs_M1	HSALNG0110725	anti_sense	Q50	hsa-miR-4534,hsa-miR-6775-3p	-	MYL11	ROR1
ENSG00000254233	LINC02365	1.33612825493202	0.0113399806764384	M2_vs_M1	HSALNG0039030	integenic	Not conserved	NA	NA	CASP3	OLFML2A
ENSG00000287543	ENSG00000287543	-3.81830238478941	1.86924322760769e-17	M2_vs_M1	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	IKZF1
ENSG00000117242	PINK1-AS	1.31376175643857	8.82591585700508e-6	M2_vs_M1	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	LRCH3
ENSG00000237927	ENSG00000237927	-3.98743634900881	4.12224801015486e-5	M2_vs_M1	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	LRCH3
ENSG00000250033	SLC7A11-AS1	-4.36992680219531	1.7593113510192e-4	M2_vs_M1	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	ZNF17
ENSG00000273972	ENSG00000273972	-2.12648300577929	0.00871169712176567	M2_vs_M1	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	ZFP91
ENSG00000264707	L3MBTL4-AS1	1.28095738667447	3.57171255053639e-5	M2_vs_M1	HSALNG0119795	anti_sense	Q50	NA	NA	ARHGAP28	EPOR
ENSG00000214870	LINC02981	1.74206891860587	1.13190446438332e-8	M2_vs_M1	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	TLR5
ENSG00000290928	ENSG00000290928	1.1601657712548	0.00388287935856223	M2_vs_M1	HSALNG0115658	integenic	Not conserved	NA	NA	ATAD5	B3GLCT
ENSG00000262097	LINC02185	4.39283422574306	4.74003777272317e-57	M2_vs_M1	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	SRGAP3
ENSG00000226281	ENSG00000226281	2.54381557595159	3.744161974750919e-100	M2_vs_M1	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	EVL
ENSG00000255443	CD44-AS1	-2.2591074954083	1.9104239610078e-4	M2_vs_M1	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	HSH2D
ENSG00000266402	SNHG25	2.41239217544249	0.00238369009371158	M2_vs_M1	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	ARHGEF12
ENSG00000260943	LINC02555	-2.40784582434013	0.0288626552708189	M2_vs_M1	HSALNG0090479	integenic	Q50	NA	Inflammatory bowel disease,Low density lipoprotein cholesterol measurement,Mean platelet volume; Platelet count,Bacteriemia,-	SLC2A13	AP2A1
ENSG00000226777	FAM30A	1.07110683781182	0.0169793731113237	M2_vs_M1	HSALNG0104257	integenic	Not conserved	NA	NA	TMEM121	WDR45
ENSG00000274515	ENSG00000274515	-5.41396896346826	0.00459349402475485	M2_vs_M1	HSALNG0107305	intronic_antisense	Q50	hsa-miR-6787-3p	NA	SNX33	ZMYM1
ENSG00000234142	LINC01675	-5.87400371189202	5.0137593317168e-4	M2_vs_M1	HSALNG0008185	integenic	Q75	NA	-	FAM78B	SLC25A29
ENSG00000256262	USP30-AS1	-2.82543985554563	1.83193533288752e-50	M2_vs_M1	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CR1L
ENSG00000291223	FAM86DP	1.49749597221257	1.1066269441332698e-11	M2_vs_M1	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	H4C16
ENSG00000254703	SENCR	1.8941411907249	8.53730032275771e-7	M2_vs_M1	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	ZNF71
ENSG00000181577	LINC03040	-2.79140402650727	2.68801705351283e-9	M2_vs_M1	NA	NA	NA	NA	NA	TMEM63B	MT1F
ENSG00000272666	KLHDC7B-DT	-4.87236277760599	1.06127169180955e-14	M2_vs_M1	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	MT1F
ENSG00000231233	CFAP58-DT	-1.26239980704509	6.7340162696997e-4	M2_vs_M1	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	F5
ENSG00000249249	TICAM2-AS1	-3.47132709980495	9.54402918191281e-6	M2_vs_M1	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	L3MBTL3
ENSG00000269889	ENSG00000269889	-5.17810107391209	0.0237932576529938	M2_vs_M1	HSALNG0030592	anti_sense	Q50	hsa-miR-941,hsa-miR-6816-5p	Sex hormone-binding globulin measurement; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil percentage of granulocytes; Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Lung adenocarcinoma,Neutrophil percentage of leukocytes,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Erythrocyte count,-	MYNN	RNU6-1099P
ENSG00000290999	ENSG00000290999	-3.36079935777005	4.00309934015967e-5	M2_vs_M1	NA	NA	NA	NA	NA	SEC22B	TATDN3
ENSG00000291135	FCGR1BP	-3.56425500672146	4.20634356128573e-13	M2_vs_M1	NA	NA	NA	NA	NA	SRGAP2C	MIR29B2CHG
ENSG00000205057	CLLU1-AS1	-2.87588464788206	4.1874728265736496e-26	M2_vs_M1	NA	NA	NA	NA	NA	BTG1	LINC00963
ENSG00000248187	ENSG00000248187	4.24355607725968	1.28830152876248e-200	M2_vs_M1	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	TMEM273
ENSG00000267745	ENSG00000267745	-2.95668547027135	0.00354767674998242	M2_vs_M1	HSALNG0115943	integenic	Not conserved	NA	-	SLFN12	SYT15
ENSG00000254254	PENK-AS1	-5.30108010628505	0.0105485056293173	M2_vs_M1	HSALNG0065478	integenic	Q75	hsa-miR-4296	NA	CHCHD7	NBDY
ENSG00000276462	LINC03025	-7.83634477603491	2.27268173185077e-74	M2_vs_M1	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	TMEM51-AS2
ENSG00000235703	EOLA2-DT	1.1308027628185	3.00671121959869e-6	M2_vs_M1	HSALNG0140629	integenic	Q50	hsa-miR-4640-3p	NA	HSFX4	AIF1
ENSG00000261888	ENSG00000261888	3.95643672531363	4.38111985330771e-26	M2_vs_M1	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	TRIM27
ENSG00000284734	ENSG00000284734	-5.18004649131567	0.0230384394067515	M2_vs_M1	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	SCGB2B2
ENSG00000281920	ENSG00000281920	6.17663630794148	1.379681429251e-4	M2_vs_M1	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	SMG1P2
ENSG00000290399	ENSG00000290399	-3.60500411838771	5.6996959596558e-6	M2_vs_M1	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	C22orf42
ENSG00000290710	HLA-V	-2.67044832328212	5.57341419672957e-5	M2_vs_M1	NA	NA	NA	NA	NA	HLA-G	HLA-A
ENSG00000272341	ENSG00000272341	2.19572007398716	9.02601698337825e-16	M2_vs_M1	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	TRIM71
ENSG00000269293	ZSCAN16-AS1	1.07379374203833	2.92878509293003e-8	M2_vs_M1	HSALNG0048933	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-7150	NA	OR2B8P	TRBJ2-3
ENSG00000259668	ENSG00000259668	-1.09201736350631	6.0731537890558e-8	M2_vs_M1	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	RPL18AP3
ENSG00000289298	ENSG00000289298	1.48272490343477	1.6723095528183e-4	M2_vs_M1	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	PIGCP1
ENSG00000289071	ENSG00000289071	-2.9515415988347	0.0319301347052627	M2_vs_M1	NA	NA	NA	NA	NA	CD46	EML6
ENSG00000267288	ENSG00000267288	-5.17784496129687	0.0320193297405541	M2_vs_M1	HSALNG0116825	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-6802-5p	Balding measurement,-	PLCD3	ENSG00000216285
ENSG00000273855	ENSG00000273855	1.30171753505484	1.9503542632505e-4	M2_vs_M1	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	FNIP1
ENSG00000237310	LINC03011	1.01750425642261	0.0173009112202984	M2_vs_M1	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	MIR1286
ENSG00000285907	ENSG00000285907	-4.52055693939138	1.21019540598035e-7	M2_vs_M1	HSALNG0072614	integenic	Q50	hsa-miR-619-5p,hsa-miR-4455,hsa-miR-6826-3p	Body mass index; Metabolic syndrome,Risk-taking behaviour,Triglyceride measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Grip strength measurement; Body mass index,Visceral adipose tissue measurement,Body mass index,Chronotype measurement,Fibrinogen measurement; Cortical thickness,Cleft lip; Cleft palate,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Triglyceride measurement; Chronotype measurement,Neuroimaging measurement; Brain measurement,Age at menarche,Cortical surface area measurement; Hemoglobin measurement; Hematocrit; Mathematical ability,Hematocrit,Cognitive function measurement,Mathematical ability,-	SEMA4D	FADS3
ENSG00000222042	ENSG00000222042	-6.22197013266086	2.6050841226131e-4	M2_vs_M1	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	ENSG00000222042
ENSG00000267481	ENSG00000267481	1.38545266462633	0.0161365619688237	M2_vs_M1	HSALNG0124757	sense	Not conserved	hsa-miR-619-5p	-	ZNF506	ENSG00000223343
ENSG00000230825	LINC03016	-4.73450452364927	0.0485608197770301	M2_vs_M1	HSALNG0056038	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290	Smooth surface dental caries,Daytime rest measurement,Body mass index; Visceral adipose tissue measurement	C1GALT1	LINC02068
ENSG00000227155	DOCK8-AS2	-1.13461425911145	0.0118888796630846	M2_vs_M1	HSALNG0069538	anti_sense	Q90	hsa-miR-4268,hsa-miR-4743-3p	Bilirubin measurement,Hair morphology measurement,-	ZNG1A	MIR503HG
ENSG00000235545	DOCK7-DT	4.06259750145278	1.5547851569678e-4	M2_vs_M1	HSALNG0004080	anti_sense	Q50	NA	Serum metabolite measurement,High density lipoprotein cholesterol measurement,Platelet count,Triglyceride measurement,Mean corpuscular volume,Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Blood metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Bilirubin measurement,-	ATG4C	NQO2-AS1
ENSG00000258404	LINC02320	2.43660375674073	3.0837748855872e-4	M2_vs_M1	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	SLC9A3-AS1
ENSG00000285190	ENSG00000285190	6.14714043845209	3.9184099794025e-5	M2_vs_M1	HSALNG0043300	anti_sense	Q50	hsa-miR-7703	Body mass index,Body height,-	RASA1	ARL6IP1P2
ENSG00000271474	UNC5C-AS1	-6.02389987735714	4.5889329253672e-4	M2_vs_M1	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	CYP4A22-AS1
ENSG00000229953	BCAN-AS2	1.23035019221715	0.015245317030361	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	ENSG00000225963
ENSG00000242258	LINC00996	-8.61396051710104	2.5041492669337103e-21	M2_vs_M1	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	HAR1A
ENSG00000248809	LINC01095	-5.30047465151865	0.018664781724686	M2_vs_M1	HSALNG0037693	integenic	Q50	hsa-miR-1227-5p,hsa-miR-6802-5p,hsa-miR-6819-5p,hsa-miR-1273h-5p	Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio; Response to bronchodilator,-	SLC10A7	PSMC1P12
ENSG00000229664	ENSG00000229664	-5.61527061621915	0.00391780160096043	M2_vs_M1	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17	PSMC1P12
ENSG00000250802	ZBED3-AS1	2.72716777907751	2.5762670474778398e-28	M2_vs_M1	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA	FTLP3
ENSG00000233610	LINC00462	-5.17878572045085	0.0151973359174884	M2_vs_M1	HSALNG0097004	anti_sense	Not conserved	NA	NA	RCBTB2	MAGOH-DT
ENSG00000223749	MIR503HG	-1.95094906567412	9.1426041013201e-6	M2_vs_M1	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1	DOCK8-AS2
ENSG00000283213	ENSG00000283213	1.62314926747835	7.1215905133459e-4	M2_vs_M1	HSALNG0110217	anti_sense	Q90	NA	-	USP31	SUB1P1
ENSG00000260351	ENSG00000260351	2.46186336112303	3.51018282086344e-5	M2_vs_M1	HSALNG0144425	integenic	Q75	NA	NA	TM6SF1	WASH7P
ENSG00000260898	ADPGK-AS1	1.38461143519113	7.34938039133481e-11	M2_vs_M1	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	KLLN
ENSG00000224652	LINC00885	2.18823344143803	6.052382209095481e-9	M2_vs_M1	HSALNG0031897	integenic	Not conserved	hsa-miR-920,hsa-miR-3169,hsa-miR-6133	Hba1c measurement,Mean corpuscular volume; Erythrocyte count,-	SLC51A	RPL11P1
ENSG00000227544	LINC03013	3.53921706361936	0.00558835640244328	M2_vs_M1	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	LINC03013
ENSG00000269667	ENSG00000269667	-5.04555505567382	0.0225364246145837	M2_vs_M1	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8	ST13P21
ENSG00000222017	ENSG00000222017	-5.04555455790025	0.0216622179909112	M2_vs_M1	HSALNG0021397	anti_sense,sense	Not conserved	hsa-miR-4268	Monocyte count,Red blood cell distribution width,Circadian rhythm,Chronotype measurement,Rheumatoid arthritis,Platelet count,Brain aneurysm,Body mass index,-	MARS2	ST13P21
ENSG00000289197	ENSG00000289197	-4.73450443542792	0.0483043113474854	M2_vs_M1	HSALNG0039059	integenic	Not conserved	NA	Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	HELT	ST13P21
ENSG00000228923	ENSG00000228923	-5.87400256244113	4.3297967054095e-4	M2_vs_M1	HSALNG0134504	sense	Q75	hsa-miR-6810-3p	Serum gamma-glutamyl transferase measurement	UPB1	ST13P21
ENSG00000226239	ENSG00000226239	-5.51844847692623	0.00466983603802474	M2_vs_M1	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	ST13P21
ENSG00000271931	PNRC1-DT	-6.15903443175511	1.5378601039939e-4	M2_vs_M1	HSALNG0051848	integenic	Q50	hsa-miR-4492,hsa-miR-6803-5p,hsa-miR-6810-3p	Sleep duration	SRSF12	ST13P21
ENSG00000290041	ENSG00000290041	-1.91397456340767	7.12203513153857e-13	M2_vs_M1	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	HLA-U
ENSG00000228382	ITPKB-IT1	3.17925472600011	0.03519491698239	M2_vs_M1	HSALNG0011101	sense	Q75	NA	NA	ITPKB	ITPKB-IT1
ENSG00000291224	ENSG00000291224	1.14375565187288	0.0121499399848876	M2_vs_M1	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2	HDAC2-AS2
ENSG00000259540	ENSG00000259540	-4.89832720170681	0.0322865716812782	M2_vs_M1	HSALNG0108586	anti_sense	Not conserved	NA	-	ASB7	HCG22
ENSG00000288819	ENSG00000288819	-2.46531598873679	0.00335967622243053	M2_vs_M1	NA	NA	NA	NA	NA	CATIP	LINC02766
ENSG00000278112	ENSG00000278112	3.12759863049569	0.00288848701442295	M2_vs_M1	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p	NA	RILPL1	LINC02800
ENSG00000242973	TDRD6-AS1	-3.4323250171051	0.00247295232827843	M2_vs_M1	HSALNG0050369	anti_sense	Q50	hsa-miR-567,hsa-miR-4447	Hashimoto's thyroiditis; Autoimmune thyroid disease; Graves disease,-	PLA2G7	RPL10P6
ENSG00000275180	ENSG00000275180	-1.38987417817164	9.55235433955297e-6	M2_vs_M1	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	RPS23P8
ENSG00000234327	ZNF232-AS1	1.28424443256108	0.00140538815365509	M2_vs_M1	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3	FBXW4P1
ENSG00000272768	ENSG00000272768	1.09659971177336	0.0163204084930821	M2_vs_M1	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA	ENSG00000230747
ENSG00000247708	STX18-AS1	1.1002628711121	3.0191223164594806e-15	M2_vs_M1	HSALNG0032553	integenic	Q50	NA	NA	MSX1	ANKRD63
ENSG00000254545	ENSG00000254545	1.55207092579757	0.0401956964763167	M2_vs_M1	HSALNG0002264	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-4498	-	HCRTR1	MORF4L2-AS1
ENSG00000233030	ENSG00000233030	-7.52005783239568	2.18258224843236e-11	M2_vs_M1	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	TAPBP
ENSG00000267519	MIR23AHG	-1.1749125866066	3.20915956585643e-31	M2_vs_M1	HSALNG0124251	anti_sense	Q90	NA	Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1	RPL4P2
ENSG00000255135	EMSY-DT	1.71200665534994	3.9618581555978e-4	M2_vs_M1	HSALNG0085855	anti_sense	Q90	hsa-miR-30c-2-3p,hsa-miR-619-5p	Microglial activation measurement,-	THAP12	ZDHHC20P4
ENSG00000232618	HIVEP2-DT	-6.55331089332059	2.70209846353329e-5	M2_vs_M1	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	HIVEP2-DT
ENSG00000232680	ENSG00000232680	-5.52013250926633	0.0119502709442095	M2_vs_M1	HSALNG0125614	integenic	Not conserved	NA	NA	KRTDAP	ENSG00000232680
ENSG00000229922	LINC02865	-5.52011787033609	0.0117267977213834	M2_vs_M1	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	ENSG00000232680
ENSG00000277425	ENSG00000277425	-5.04524725136067	0.0277419769568479	M2_vs_M1	HSALNG0128363	sense	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	TMEM230	MARK2P9
ENSG00000254287	ENSG00000254287	-10.115660789955	1.9956100747919e-49	M2_vs_M1	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	ENSG00000233029
ENSG00000266049	ENSG00000266049	1.39865744079415	0.0151973359174884	M2_vs_M1	HSALNG0119656	anti_sense	Not conserved	hsa-miR-6089	Fat body mass,Nicotine withdrawal symptom count,Mathematical ability,Body height,Response to radiation,-,Conotruncal heart malformations	LPIN2	GPX1
ENSG00000267074	ENSG00000267074	-2.57511139821289	3.54663692628469e-5	M2_vs_M1	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	ENSG00000233785
ENSG00000262001	DLGAP1-AS2	-1.36208500717322	0.0495083300407904	M2_vs_M1	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	LINC01283
ENSG00000287893	ENSG00000287893	3.65764432696624	0.00655551520054547	M2_vs_M1	HSALNG0057241	integenic	Not conserved	NA	-	HERPUD2	LINC02925
ENSG00000236790	LINC00299	-5.79246415983861	0.00165588470832371	M2_vs_M1	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	ATP5PDP4
ENSG00000236404	VLDLR-AS1	4.78909117553286	0.0335189482092139	M2_vs_M1	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	EIF4BP9
ENSG00000290525	GBP1P1	-7.25250770463343	1.07339002720256e-51	M2_vs_M1	NA	NA	NA	NA	NA	GBP6	LINC01358
ENSG00000270605	ENSG00000270605	-1.65567243503841	0.00258977189076118	M2_vs_M1	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	LINC01679
ENSG00000289015	ENSG00000289015	1.00260679333056	0.0444362343921223	M2_vs_M1	HSALNG0058614	anti_sense	Not conserved	NA	-	SBDS	ASB14
ENSG00000290644	ENSG00000290644	2.72319588666111	0.0220098192143265	M2_vs_M1	HSALNG0072753	integenic	Not conserved	hsa-miR-3178,hsa-miR-4505,hsa-miR-6514-3p	-	CENPP	ENSG00000239415
ENSG00000268355	ENSG00000268355	1.694642850913	0.0365933660074573	M2_vs_M1	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	KMT2E-AS1
ENSG00000225465	RFPL1S	-1.15150608690803	0.0152991664832013	M2_vs_M1	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5	TFAP2E-AS1
ENSG00000215244	LINC02649	-1.06902583616483	0.0198180114947971	M2_vs_M1	HSALNG0142500	integenic	Not conserved	NA	Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3	ENSG00000242588
ENSG00000271040	TMEM242-DT	2.55447502401297	0.00318838190861832	M2_vs_M1	HSALNG0054615	anti_sense	Not conserved	NA	-	ZDHHC14	ENSG00000243304
ENSG00000286276	ENSG00000286276	-1.42175038231843	0.00775793039442015	M2_vs_M1	HSALNG0006333	integenic	Q50	hsa-miR-615-5p,hsa-miR-4519	Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Stressful life event measurement; Depressive symptom measurement,-	ATP1A1	EFNA4
ENSG00000167920	KRT10-AS1	1.07852024705963	0.00236176615078098	M2_vs_M1	HSALNG0116399	anti_sense	Q75	hsa-miR-3960	Leukocyte count,-	KRTAP4-7	IL10RB
ENSG00000289198	ENSG00000289198	-1.9953791609066	6.48359081354593e-5	M2_vs_M1	HSALNG0052920	integenic	Q90	NA	-	MARCKS	APOBEC3D
ENSG00000236939	BAALC-AS2	-3.30074386392147	4.3769976364952e-35	M2_vs_M1	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	RN7SL832P
ENSG00000235979	ENSG00000235979	5.51598898743957	0.00585680918469797	M2_vs_M1	HSALNG0115130	integenic	Not conserved	NA	NA	MFAP4	VTI1BP1
ENSG00000265205	ENSG00000265205	-2.20054547666339	0.0190566473466056	M2_vs_M1	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2	LINC00847
ENSG00000259407	ENSG00000259407	-4.89901200763136	0.0467300470783628	M2_vs_M1	HSALNG0107883	anti_sense	Q90	hsa-miR-4492,hsa-miR-2467-3p,hsa-miR-7843-5p	Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Eosinophil count,Systolic blood pressure,Eosinophil count; Eosinophil percentage of leukocytes,Alkaline phosphatase measurement,Varicose veins,Idiopathic pulmonary fibrosis,-	KLHL25	A2M-AS1
ENSG00000270120	ENSG00000270120	-3.702357663252	6.42717935231023e-7	M2_vs_M1	HSALNG0111360	sense	Q50	NA	NA	NOD2	SDAD1-AS1
ENSG00000235770	LINC00607	1.99088888930207	4.26327131518416e-9	M2_vs_M1	HSALNG0022091	integenic	Not conserved	NA	-	MREG	TMED2-DT
ENSG00000260302	LINC01882	-5.79317697918907	0.00106231936265877	M2_vs_M1	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2	LINC01093
ENSG00000259720	ENSG00000259720	3.41474325597945	0.023915910651559	M2_vs_M1	HSALNG0144346	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4430	NA	FAN1	PDLIM1P4
ENSG00000236846	ENSG00000236846	6.01344620290331	8.6344391094066e-4	M2_vs_M1	HSALNG0010877	integenic	Q50	hsa-miR-22-3p,hsa-miR-3192-5p,hsa-miR-4472,hsa-miR-6780a-3p	NA	DISP1	ENSG00000249639
ENSG00000227017	ENSG00000227017	-4.51799903794848	2.17722524812309e-7	M2_vs_M1	HSALNG0056985	integenic	Q50	NA	-	FKBP14	LINC02021
ENSG00000255571	MIR9-3HG	-5.41322261776789	0.00924267824194208	M2_vs_M1	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	CDK3
ENSG00000286062	ENSG00000286062	1.18681644529275	1.18060545221845e-5	M2_vs_M1	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	ENSG00000250568
ENSG00000287576	ENSG00000287576	-2.45791313204934	9.23156529351728e-11	M2_vs_M1	HSALNG0150312	integenic	Not conserved	NA	Leukocyte count	GSDMD	ENSG00000251194
ENSG00000253317	ENSG00000253317	-5.41397117348404	0.00463744784412099	M2_vs_M1	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	ENSG00000253317
ENSG00000234177	LINC01114	4.03499827285692	6.5574368346234e-4	M2_vs_M1	HSALNG0017537	anti_sense	Q90	hsa-miR-328-3p,hsa-miR-3196,hsa-miR-8485	Chronotype measurement,Pancreatic carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Body weight,Mean arterial pressure,Lifestyle measurement; Neuroimaging measurement; Body mass index; Brain measurement; Body height,Brain volume measurement,-	TGFBRAP1	ENSG00000253666
ENSG00000234919	LINC01827	3.23590927071799	1.93734743232569e-7	M2_vs_M1	HSALNG0021276	anti_sense	Q50	hsa-miR-4463,hsa-miR-6825-5p,hsa-miR-1273h-5p	Neuroticism measurement; Temperament and character inventory,Intelligence,Ankle injury,Food allergy measurement,Response to benznidazole,Eye colour measurement,Gut microbiome measurement,Parental longevity,Proliferative diabetic retinopathy,Blood urea nitrogen measurement,Abnormality of chromosome segregation,Interleukin 2 measurement,Lymphoid leukemia,Bipolar disorder; Attention deficit hyperactivity disorder,Response to thiopurine; Leukopenia,Response to antimicrotubule agent; Response to antineoplastic agent,-	DNAH7	ENSG00000253667
ENSG00000233029	ENSG00000233029	-5.70739769018196	0.00272336388041652	M2_vs_M1	HSALNG0142289	anti_sense	Not conserved	NA	-	FAM72B	ENSG00000254287
ENSG00000272405	ENSG00000272405	1.27189960809536	3.1849928414519e-11	M2_vs_M1	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	EMSY-DT
ENSG00000272482	ENSG00000272482	4.78872234030856	0.0228866147193639	M2_vs_M1	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	HTD2
ENSG00000279833	ENSG00000279833	1.37966436622684	0.00923444873337331	M2_vs_M1	NA	NA	NA	NA	NA	APOBEC3H	ENSG00000255860
ENSG00000272941	ENSG00000272941	-1.16102720316654	3.4368883608426e-4	M2_vs_M1	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	ENSG00000255968
ENSG00000261373	VPS9D1-AS1	-1.4522792446093	0.00488721145698014	M2_vs_M1	HSALNG0141629	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-4732-3p,hsa-miR-6808-5p	Blood protein measurement,Hair colour measurement,-	ZNF276	TOMM20P2
ENSG00000250548	LINC01303	-3.00612899474403	2.56075149905542e-8	M2_vs_M1	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	CTSO
ENSG00000228013	IL6R-AS1	-2.42039504725123	1.62166139866621e-8	M2_vs_M1	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE	ENSG00000256196
ENSG00000247081	BAALC-AS1	-2.85816281605132	1.14356490545928e-5	M2_vs_M1	HSALNG0067506	integenic	Q50	NA	NA	SLC25A32	TMEM109-DT
ENSG00000240057	NEPRO-AS1	-1.41927834092058	0.0197102892451092	M2_vs_M1	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	GLIPR1-AS1
ENSG00000257588	AQP5-AS1	5.44078374321274	0.00515869226453883	M2_vs_M1	HSALNG0090990	anti_sense	Q50	NA	-	RACGAP1	AQP5-AS1
ENSG00000287917	ENSG00000287917	-1.24714041594379	0.00409460492398302	M2_vs_M1	HSALNG0084879	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3620-3p,hsa-miR-6089,hsa-miR-6803-5p	-	SLC25A45	C17orf49
ENSG00000225138	SLC9A3-AS1	1.2025270060265	1.14941179444467e-5	M2_vs_M1	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	LINC02320
ENSG00000287255	ENSG00000287255	2.72928466599729	6.6498286273188e-4	M2_vs_M1	HSALNG0014389	anti_sense	Q50	hsa-miR-619-5p	Qt interval; Pr interval,Qt interval,Pr interval,Protein measurement,Qt interval; Tpe interval measurement,Electrocardiography,Bone fracture,Dna methylation,Heel bone mineral density,Forced expiratory volume; Response to bronchodilator,-	TMEM178A	ENSG00000258634
ENSG00000259094	ENSG00000259094	5.61828103951459	5.7818768720255e-4	M2_vs_M1	HSALNG0018295	anti_sense	Not conserved	NA	-	EN1	ENSG00000259094
ENSG00000255320	ENSG00000255320	1.22112686959215	0.0164056143585547	M2_vs_M1	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	ENSG00000259137
ENSG00000232160	RAP2C-AS1	-1.27931732896951	0.0132140287785855	M2_vs_M1	HSALNG0140185	integenic	Not conserved	NA	NA	STK26	ENSG00000259212
ENSG00000267737	ENSG00000267737	-4.02954372951014	1.06697010586794e-8	M2_vs_M1	HSALNG0119029	integenic	Not conserved	NA	NA	PGS1	SLC30A4-AS1
ENSG00000288743	ENSG00000288743	2.01412457484709	0.00859907746880651	M2_vs_M1	HSALNG0097024	overlap_antisense,anti_sense	Q50	hsa-miR-4480,hsa-miR-6747-5p,hsa-miR-7155-5p	Uterine fibroid,-	CAB39L	ENSG00000259363
ENSG00000253738	OTUD6B-AS1	1.06232335888394	8.48692138601003e-14	M2_vs_M1	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	ENSG00000259408
ENSG00000226312	CFLAR-AS1	-1.36988846723966	2.38259296871651e-6	M2_vs_M1	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	ENSG00000260257
ENSG00000249173	LINC01093	-5.9380903940663	5.87185627184889e-18	M2_vs_M1	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	LINC01882
ENSG00000260630	SNAI3-AS1	1.43014865307784	5.97285625975285e-10	M2_vs_M1	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	ENSG00000260360
ENSG00000260661	ENSG00000260661	-5.0450901486664	0.0385527720051374	M2_vs_M1	HSALNG0144613	anti_sense	Q75	NA	Diastolic blood pressure,3-hydroxy-1-methylpropylmercapturic acid measurement,Self reported educational attainment,Susceptibility to chronic sinus infection measurement,Dna methylation,Seasonal gut microbiome measurement,Parahippocampal gyrus volume measurement,Smoking initiation,Oral cleft; Alcohol consumption measurement,Colorectal cancer; Diet measurement,Serum dimethylarginine measurement,-	FAM174B	ENSG00000260661
ENSG00000291233	ENSG00000291233	-1.31158926343654	0.0476734424357067	M2_vs_M1	NA	NA	NA	NA	NA	NBPF9	ENSG00000261056
ENSG00000286558	ENSG00000286558	-2.18836465128095	0.00313514025628036	M2_vs_M1	HSALNG0148220	integenic	Not conserved	NA	-	TMEM144	VPS9D1-AS1
ENSG00000247095	MIR210HG	-3.23285051385347	8.32063113874939e-5	M2_vs_M1	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	TEN1-CDK3
ENSG00000272079	ENSG00000272079	1.49964749616388	0.0089386531971341	M2_vs_M1	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	ENSG00000261468
ENSG00000186235	LINC02610	1.4634742631139	4.12031947876956e-5	M2_vs_M1	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	YBX3P1
ENSG00000247317	LY6E-DT	-3.48283469095776	0.00775698660300046	M2_vs_M1	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	ENSG00000262362
ENSG00000267452	LINC02073	2.94368986993354	9.12003262596206e-7	M2_vs_M1	HSALNG0117381	integenic	Not conserved	NA	NA	UTP18	ZNF234
ENSG00000172965	MIR4435-2HG	1.22213498964669	2.1598047004669097e-11	M2_vs_M1	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	MIR4783
ENSG00000285736	ENSG00000285736	3.51826009897045	0.0107109249931635	M2_vs_M1	HSALNG0045746	anti_sense	Not conserved	NA	-	IL17B	NOTCH2NLA
ENSG00000224116	INHBA-AS1	-3.42930287236678	0.00290752146617552	M2_vs_M1	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	RBM8A
ENSG00000285761	ENSG00000285761	-2.2330803187269	3.60190077963141e-6	M2_vs_M1	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	ENSG00000265298
ENSG00000265479	DTX2P1-UPK3BP1-PMS2P11	-5.17897335730215	0.0158480552123057	M2_vs_M1	HSALNG0059099	anti_sense,sense	Q75	NA	Body mass index,Waist-hip ratio; Body mass index,Urinary nitrogen measurement,Response to drug,Macrovascular complications of diabetes; Diabetic eye disease,Comparative body size at age 10, self-reported,Platinum measurement; Response to cisplatin,Interleukin-6 measurement,-	CCDC146	DTX2P1-UPK3BP1-PMS2P11
ENSG00000266708	ENSG00000266708	-5.04591527971637	0.0302935985950135	M2_vs_M1	HSALNG0119876	anti_sense	Q75	NA	-	PPP4R1	ENSG00000266708
ENSG00000290034	ENSG00000290034	1.17384527911933	0.00163013111373807	M2_vs_M1	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	ENSG00000266783
ENSG00000260941	LINC00622	1.2673451592419	0.00858888395727045	M2_vs_M1	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	ENSG00000266910
ENSG00000233785	ENSG00000233785	-2.38406506444867	0.00129734073058374	M2_vs_M1	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9	ENSG00000267074
ENSG00000267130	ENSG00000267130	3.54290623459925	0.00528432520740921	M2_vs_M1	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	ENSG00000267130
ENSG00000256948	ENSG00000256948	-1.03902581956202	4.4579972440263e-4	M2_vs_M1	HSALNG0088445	anti_sense	Not conserved	hsa-miR-939-5p	Response to candesartan	SLC6A12	ENSG00000267149
ENSG00000287245	ENSG00000287245	1.88140637280229	0.0176482267708751	M2_vs_M1	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	ENSG00000267219
ENSG00000258583	LINC01500	6.11226727479734	4.3026279340977394e-45	M2_vs_M1	HSALNG0101652	integenic	Not conserved	NA	NA	DACT1	LINC02073
ENSG00000258919	ENSG00000258919	1.9608446041584	1.11911733289662e-5	M2_vs_M1	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	EDDM13
ENSG00000259354	ENSG00000259354	-4.29396496937559	2.7608702828386993e-44	M2_vs_M1	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	ENSG00000267737
ENSG00000236914	LINC01852	-3.2157636824127	0.0113086009733463	M2_vs_M1	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1	ZNF460-AS1
ENSG00000255026	ENSG00000255026	-2.25740954618059	0.00274715977820043	M2_vs_M1	HSALNG0081949	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-766-3p	NA	PGGHG	ENSG00000269044
ENSG00000286698	ENSG00000286698	5.50708595462248	0.00382352002569018	M2_vs_M1	HSALNG0016845	integenic	Not conserved	NA	NA	EIF2AK3	PLEKHA3P1
ENSG00000269959	SPACA6-AS1	-5.18004569126739	0.023020796658988	M2_vs_M1	HSALNG0127249	anti_sense	Q75	NA	Calcium measurement,Body height,-	HAS1	SPACA6-AS1
ENSG00000245928	SDAD1-AS1	-6.93877293403326	5.40657745837956e-7	M2_vs_M1	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	ENSG00000270120
ENSG00000233392	UICLM	7.98457600146602	2.2430128348057706e-15	M2_vs_M1	HSALNG0023633	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-4492,hsa-miR-6791-5p	NA	MAB21L4	ENSG00000270127
ENSG00000225077	ICMT-DT	-5.70715723558172	0.00338403187826407	M2_vs_M1	HSALNG0000511	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4650-5p,hsa-miR-6089	Qt interval,Resting heart rate,-	HES3	ENSG00000270681
ENSG00000206344	HCG27	-1.75330289479255	0.0032021310442967	M2_vs_M1	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	MILR1
ENSG00000230537	LINC02937	5.18717895624246	0.0129406417624084	M2_vs_M1	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	ENSG00000271992
ENSG00000230747	ENSG00000230747	2.57389243857351	1.47136258217054e-9	M2_vs_M1	HSALNG0017036	sense	Not conserved	NA	Hemoglobin a1 measurement; Unipolar depression,-	SNRNP200	ENSG00000272768
ENSG00000291258	ENSG00000291258	-3.21162630179082	0.00845518894501293	M2_vs_M1	HSALNG0144341	overlap_antisense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	APBA2	ENSG00000272787
ENSG00000272839	ENSG00000272839	1.56059755691462	0.00167114184148806	M2_vs_M1	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	ENSG00000272812
ENSG00000288066	ENSG00000288066	1.01580586698713	7.8351674812549e-4	M2_vs_M1	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	ENSG00000272941
ENSG00000253593	ENSG00000253593	-2.95490616843987	0.0268276678253969	M2_vs_M1	HSALNG0068775	integenic	Not conserved	hsa-miR-6873-3p	Response to alcohol	CCN4	LCDR
ENSG00000260804	LINC01963	1.83930446457233	8.1184343011165e-9	M2_vs_M1	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	TM4SF19-DYNLT2B
ENSG00000234630	ENSG00000234630	2.23321252637303	0.0210592838441201	M2_vs_M1	HSALNG0134317	integenic	Not conserved	hsa-miR-874-3p,hsa-miR-6775-3p	NA	VPREB1	ENSG00000273486
ENSG00000253351	LINC01298	7.87674016381238	4.84928810381946e-16	M2_vs_M1	HSALNG0067084	integenic	Q50	hsa-miR-30b-3p,hsa-miR-331-3p,hsa-miR-4308,hsa-miR-5572	Low density lipoprotein cholesterol measurement	CFAP418	ENSG00000274944
ENSG00000259871	ENSG00000259871	6.59636131820669	1.35446573886854e-6	M2_vs_M1	HSALNG0109998	sense	Not conserved	hsa-miR-8485	NA	CLEC19A	ENSG00000274944
ENSG00000254654	LINC02685	6.04754493677201	1.8260612134699e-4	M2_vs_M1	HSALNG0083903	integenic	Q50	hsa-miR-30b-3p	-	TSPAN18	ENSG00000274944
ENSG00000228536	LYPLAL1-AS1	5.34830495108214	0.0140592026572177	M2_vs_M1	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B	ENSG00000274944
ENSG00000234211	ENSG00000234211	4.99200299691505	0.0173750382292113	M2_vs_M1	HSALNG0007963	anti_sense	Q75	NA	Rheumatoid arthritis,Aspartate aminotransferase measurement,Erythrocyte count,Monocyte percentage of leukocytes,-	FCGR3B	ENSG00000274944
ENSG00000235407	CYMP-AS1	4.7517348849588	0.031816573816105	M2_vs_M1	HSALNG0005984	integenic	Not conserved	NA	-	KCNA10	ENSG00000274944
ENSG00000229525	DNPEP-AS1	4.78935855799294	0.0462855190268235	M2_vs_M1	HSALNG0022376	anti_sense,sense	Q50	NA	-	DES	ENSG00000274944
ENSG00000233251	ENSG00000233251	5.02414635379214	0.0261145745615438	M2_vs_M1	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ENSG00000274944
ENSG00000251136	RIPK2-DT	-2.72828897882736	4.443933592089938e-112	M2_vs_M1	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	MLLT6
ENSG00000260135	MMP2-AS1	-2.337754003012	2.68002873937495e-26	M2_vs_M1	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	PRAG1
ENSG00000275431	ENSG00000275431	-5.30112633292868	0.00941896649698527	M2_vs_M1	HSALNG0115994	anti_sense	Q50	NA	Blood protein measurement,Eyelid sagging measurement,C-c motif chemokine 15 measurement	CCL18	ENSG00000275431
ENSG00000248693	LINC02100	-3.21576785330315	0.011313425894371	M2_vs_M1	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	BACE1-AS
ENSG00000282572	FAM157D	-1.7528562382699	0.015284453300457	M2_vs_M1	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	ENSG00000278861
ENSG00000289947	ENSG00000289947	-3.12471429754325	0.0200866147504385	M2_vs_M1	NA	NA	NA	NA	NA	ODF3B	ENSG00000279605
ENSG00000263164	ENSG00000263164	3.18853921251929	0.0295565532133468	M2_vs_M1	HSALNG0114111	anti_sense,sense	Not conserved	NA	Head and neck squamous cell carcinoma,Family history of alzheimer’s disease,Sex hormone-binding globulin measurement,Leukocyte count,Red blood cell density measurement,-	SCIMP	ENSG00000279803
ENSG00000197180	ATP6AP1-DT	1.26814334496286	1.63725843873184e-17	M2_vs_M1	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	ENSG00000279805
ENSG00000261094	ENSG00000261094	-1.66643568095321	2.6259718029528e-4	M2_vs_M1	HSALNG0074265	integenic	Q50	NA	Birth weight; Neuroimaging measurement; Brain volume measurement,-	RABGAP1	ENSG00000279900
ENSG00000248538	PPP1R3B-DT	5.2793386049025	0.0288390080858901	M2_vs_M1	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	DDX11L17
ENSG00000244586	WNT5A-AS1	-6.39603902569663	1.4904070772388e-4	M2_vs_M1	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	LINC03032
ENSG00000286696	ENSG00000286696	1.30211165407545	0.0192810464303016	M2_vs_M1	HSALNG0144397	anti_sense	Q75	NA	NA	CCDC33	ENSG00000280181
ENSG00000284722	ENSG00000284722	3.6852954355154	0.00269363309976049	M2_vs_M1	NA	NA	NA	NA	NA	OR2AT4	ENSG00000281530
ENSG00000282221	ENSG00000282221	-5.30245264077417	0.0170686373824723	M2_vs_M1	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1	ENSG00000282221
ENSG00000259760	ENSG00000259760	1.20622936524133	5.04005391300409e-27	M2_vs_M1	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	ENSG00000283041
ENSG00000226862	ENSG00000226862	4.75229676900355	0.0313673319953584	M2_vs_M1	HSALNG0009734	anti_sense,sense	Q75	hsa-miR-328-3p,hsa-miR-574-5p,hsa-miR-4453,hsa-miR-4486	Cortical surface area measurement,-	PPP1R12B	ENSG00000284830
ENSG00000254248	ENSG00000254248	5.26206646748536	0.00337924738547545	M2_vs_M1	HSALNG0067071	anti_sense	Not conserved	hsa-miR-6763-5p	Serum alanine aminotransferase measurement,-	TP53INP1	ENSG00000284830
ENSG00000253924	ENSG00000253924	4.84022020537478	0.0383903831878038	M2_vs_M1	HSALNG0065257	anti_sense	Q90	NA	NA	NPBWR1	ENSG00000284830
ENSG00000289548	ENSG00000289548	5.98175168286951	2.5424575087526e-4	M2_vs_M1	HSALNG0146881	integenic	Not conserved	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6859-3p	NA	SLCO4A1	ENSG00000284830
ENSG00000258512	LINC00239	1.84252975258986	3.6193425482223e-4	M2_vs_M1	HSALNG0103853	integenic	Not conserved	hsa-miR-4447	NA	PPP2R5C	ENSG00000285130
ENSG00000267549	ZSCAN5A-AS1	1.88415364977743	0.0018474680740114	M2_vs_M1	HSALNG0127749	anti_sense	Not conserved	NA	-	EDDM13	SOD2-OT1
ENSG00000251301	LINC02384	-6.84630308331332	4.0673062931225974e-236	M2_vs_M1	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	ENSG00000285744
ENSG00000273272	ENSG00000273272	-5.04556035713239	0.0377369059340913	M2_vs_M1	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ENSG00000286707
ENSG00000237248	LINC00987	-2.4768284079758	0.0442807068060083	M2_vs_M1	HSALNG0089130	integenic	Q50	hsa-miR-619-5p,hsa-miR-6769b-5p	-	KLRG1	ENSG00000286909
ENSG00000224666	ETV7-AS1	-5.41379856885578	0.00528743374155523	M2_vs_M1	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	ENSG00000287335
ENSG00000287335	ENSG00000287335	-5.41370376602105	0.00625852645187772	M2_vs_M1	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	ENSG00000287335
ENSG00000259225	LINC02345	2.73265201455691	1.11988718006045e-15	M2_vs_M1	HSALNG0105099	integenic	Not conserved	NA	NA	TMCO5A	ENSG00000287378
ENSG00000260542	ENSG00000260542	2.25568260046683	0.00190098555483577	M2_vs_M1	HSALNG0131538	integenic	Not conserved	NA	NA	GATA5	ENSG00000287691
ENSG00000225792	SNX10-AS1	-4.51121124924745	5.656533252562518e-75	M2_vs_M1	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	ENSG00000287771
ENSG00000289372	ENSG00000289372	-5.30013878859611	0.0171671585285999	M2_vs_M1	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC	ENSG00000288064
ENSG00000235641	LINC00484	4.84195452157278	0.0401623296959503	M2_vs_M1	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	ENSG00000288111
ENSG00000271952	LINC01954	2.60027828851136	0.00700251510384237	M2_vs_M1	HSALNG0146022	overlap_sense	Not conserved	NA	Childhood aggressive behaviour measurement,Chronotype measurement,Exploratory eye movement measurement,Neuropsychological test,Mathematical ability,Fev/fec ratio; Response to bronchodilator,-	KCNF1	ENSG00000288545
ENSG00000229484	LINC02766	2.17907407770725	9.65103402585314e-5	M2_vs_M1	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	ENSG00000288819
ENSG00000251586	TET2-AS1	1.99084807321889	0.0197838678380827	M2_vs_M1	HSALNG0036166	anti_sense	Not conserved	NA	Ulcerative colitis; Intelligence; Body height,Intelligence; Testosterone measurement; Insomnia measurement; Body height; Body weight,Bmi-adjusted waist circumference; Glomerular filtration rate,Heel bone mineral density,Uric acid measurement,Leukocyte count,Forced expiratory volume,Pulse pressure measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Intelligence,Body height,Lifestyle measurement,Colorectal cancer; Household income; Colorectal adenoma,Forced expiratory volume; Chronic obstructive pulmonary disease,Trauma exposure measurement; Primary biliary cirrhosis,Fev/fec ratio; Primary biliary cirrhosis,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte percentage of leukocytes; Glomerular filtration rate; Lymphocyte count; Creatinine measurement; Neutrophil percentage of leukocytes,Neutrophil count,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Self reported educational attainment; Intelligence; Risk-taking behaviour; Hemorrhoid,Melanoma,Self reported educational attainment; Intelligence; Mathematical ability,Self reported educational attainment; Intelligence; Birth weight,Age at menarche,Tonsillectomy risk measurement,Attention deficit hyperactivity disorder; Risk-taking behaviour; Antisocial behaviour measurement; Substance abuse,Intelligence; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Self reported educational attainment,Appendicular lean mass,Platelet count,Prostate carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Risky sexual behaviour measurement,Intelligence; Risk-taking behaviour,Platelet crit,Breast carcinoma,Self reported educational attainment; Intelligence; Mathematical ability; Coffee consumption measurement; Cognitive function measurement,Intelligence; Household income,Intelligence; Lean body mass,Body weight,Neutrophil-to-lymphocyte ratio; Total blood protein measurement; Intelligence; Lymphocyte count,Health study participation,Verbal-numerical reasoning measurement,Myeloid white cell count,Testosterone measurement,Response to vaccine,Household income,Social interaction measurement,Obesity,Wellbeing measurement,Bmi-adjusted hip circumference,Forced expiratory volume; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Nevus count; Cutaneous melanoma,Body height; Pulse pressure measurement; Chronic obstructive pulmonary disease,-,Forced expiratory volume; Birth weight; Chronic obstructive pulmonary disease; Fev/fec ratio; Peak expiratory flow; Smoking status measurement,Coffee consumption measurement; Tea consumption measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement; Bmi-adjusted waist-hip ratio,Serum non-albumin protein measurement	PPA2	ENSG00000288927
ENSG00000272986	ENSG00000272986	-5.04446736179389	0.0465671237563101	M2_vs_M1	HSALNG0035038	anti_sense	Q50	NA	NA	JCHAIN	ENSG00000288952
ENSG00000272269	NUP153-AS1	-1.4733425032203	0.00666881650221221	M2_vs_M1	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	ENSG00000289071
ENSG00000287091	ENSG00000287091	1.53423921140656	0.0144949771660103	M2_vs_M1	HSALNG0146641	sense	Q50	hsa-miR-1203	NA	CD302	ENSG00000289294
ENSG00000289331	ENSG00000289331	-4.89857022229019	0.0421985210815456	M2_vs_M1	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	ENSG00000289331
ENSG00000291186	ENSG00000291186	1.27016786040918	7.8951289380985e-4	M2_vs_M1	NA	NA	NA	NA	NA	DEFB108B	ENSG00000289470
ENSG00000289530	ENSG00000289530	-5.41308531145974	0.0112660515037706	M2_vs_M1	HSALNG0035158	integenic	Q50	NA	-	RASSF6	ENSG00000289530
ENSG00000285239	ENSG00000285239	-5.41321354135274	0.00935603701792785	M2_vs_M1	HSALNG0142409	anti_sense	Not conserved	NA	NA	CD34	ENSG00000289530
ENSG00000290735	ENSG00000290735	-4.03551744376841	1.1371558465256e-4	M2_vs_M1	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	ENSG00000289701
ENSG00000286248	ENSG00000286248	-1.17715044119101	0.00526221199771578	M2_vs_M1	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	ENSG00000289745
ENSG00000289958	ENSG00000289958	4.78860426663892	0.0205144785871993	M2_vs_M1	HSALNG0048244	integenic	Not conserved	NA	-	MCUR1	ENSG00000289958
ENSG00000237499	WAKMAR2	-2.35804038510833	1.35868255253055e-10	M2_vs_M1	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	ENSG00000290041
ENSG00000253535	ADAM7-AS1	-4.75482721650448	3.17745678564378e-9	M2_vs_M1	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	TPTEP1
ENSG00000237352	LINC01358	-3.87903776352911	9.08391693205684e-27	M2_vs_M1	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	GBP1P1
ENSG00000232310	LINC03002	2.41124708758593	0.00100637284417305	M2_vs_M1	HSALNG0053635	integenic	Q75	hsa-miR-6838-5p	NA	SGK1	ENSG00000290600
ENSG00000291155	CT75	-5.11314523046016	3.8412334990103195e-11	M2_vs_M1	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2	NCF1B
ENSG00000285533	RELA-DT	1.09272896149889	6.3566039567045e-4	M2_vs_M1	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	ENSG00000290867
ENSG00000204971	ENSG00000204971	2.9084225764666	6.793830999589538e-25	M2_vs_M1	HSALNG0085534	integenic	Not conserved	hsa-miR-412-3p,hsa-miR-6769b-5p	NA	PHOX2A	ZNF252P
ENSG00000289582	ENSG00000289582	-5.14213846421528	4.61113639961851e-30	M2_vs_M1	NA	NA	NA	NA	NA	GBP2	ENSG00000291086
ENSG00000203709	MIR29B2CHG	-1.8298094675024	2.57674597298044e-67	M2_vs_M1	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	ENSG00000291135
ENSG00000269446	ENSG00000269446	1.37734933970833	1.86666812019597e-5	M2_vs_M1	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	ENSG00000291153
ENSG00000290838	NCF1B	-7.36015715898991	1.80584196071371e-9	M2_vs_M1	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	CT75
ENSG00000228624	HDAC2-AS2	1.43950362286375	4.96303617119443e-7	M2_vs_M1	HSALNG0052943	integenic	Not conserved	NA	NA	MARCKS	ENSG00000291224
